

David M. Mott: Executive Profile & Biography - Bloomberg









































  





















































































July 22, 2017 8:27 AM ET
Biotechnology

Company Overview of Mersana Therapeutics, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
David M. Mott  Executive Chairman, Mersana Therapeutics, Inc.AgeTotal Calculated CompensationThis person is connected to 16 Board Members in 16 different organizations across 25 different industries.See Board Relationships52--
Background

		Mr. David M. Mott, also known as Dave, has been a General Partner at New Enterprise Associates since September 17, 2008 and is its Partner. Mr. Mott focuses on healthcare and biopharmaceuticals investments and leads the New Enterprise healthcare investing practice. He serves as a Senior Advisor of The Royal Institute of International Affairs. He is Partner and General Partner of New Enterprise Associates 14, L.P. He serves as a Senior Advisor of Chatham House. Mr. Mott ... served as Head of Healthcare Practice at New Enterprise Associates. He has been the Executive Chairman of Mersana Therapeutics, Inc. since July 2012. He serves as an Executive Chairman of 3-V Biosciences, Inc. He served as the Executive Chairman of Prosensa Holding NV. He served as an Executive Vice President of AstraZeneca PLC since June 2007 until July 2008. He joined MedImmune Inc. in April 1992 as a Vice President with responsibility for business development, strategic planning and investor relations and assumed additional responsibility for the medical and regulatory groups, in 1994. He served as the Chief Executive Officer of MedImmune Inc. from October 2000 to July 31, 2008 and served as its President from February 2004 to July 31, 2008. Mr. Mott served as the Chief Financial Officer and Executive Vice President of MedImmune Inc. since March 1995 and served as its President and Chief Operating Officer since November 1995. From 1992 to 2008, he worked at MedImmune Limited which including Chief Operating Officer and Chief Financial Officer. He also served as the Chief Executive Officer and President of MedImmune Limited from June 18, 2007 to July 2008. In 2002, he founded MedImmune Ventures, Inc. and departed in July 2008. Prior to joining MedImmune Inc., he served as a Vice President in the Health Care Investment Banking Group at Smith Barney, Harris Upham & Co. Inc. At Smith Barney, where he was employed from July 1986 to April 1992, his activities included public and private equity and debt financings as well as merger and acquisition work for biotechnology, healthcare services and medical product and device companies. He served as Vice President of Health Care Investment Banking Group at Citigroup CIB. He has been the Chairman of Tesaro, Inc. since July 2011. He serves as the Chairman of Cydan. He serves as the Board Chair of Vtesse, Inc. He served as the Chairman of Imara, Inc. He has been Chairman of Epizyme, Inc. since April 2016. He has been the Chairman of Ardelyx, Inc. since March 2014. He serves as the Chairman of Supervisory Board at BioMarin Nederland B.V. He served as the Chairman of Conceptis Technologies, Inc. He has been the Chairman of Adaptimmune Therapeutics plc since January 1, 2017 and served as its Vice Chairman from May 2016 to December 1, 2016. He served as Chairman of 3-V Biosciences, Inc. He served as the Chairman of Zyngenia, Inc. from 2009 to 2014. Mr. Mott served as Vice Chairman of MedImmune, LLC from October 1998 to June 1, 2007. He has been Member of Supervisory Board at BioMarin Nederland B.V. since January 25, 2012 and serves as its member of the board of directors. He has been a Director of Edimer Pharmaceuticals Inc. since June 30, 2013 and Clementia Pharmaceuticals Inc. since August 2015. He serves as a Director of St Albans School and Biotechnology Innovation Organization (alternate name, Biotechnology Industry Organization (BIO)). He has been Non Executive Director of Adaptimmune Therapeutics plc since February 2015. He has been an Independent Director of Ardelyx, Inc. since March 2009. He has been an Independent Director of Epizyme, Inc. since December 2009. He serves as a Member of Advisory Board at Scripps Translational Science Institute (stsi), Board of Trustees of St. James School and on the Board of Governors of Beauvoir, the National Cathedral Elementary School. He has been a Member of the Board of Directors of NightstaRx Limited. He has been a Director of Tesaro, Inc since May 2010 and XTuit Pharmaceuticals, Inc. since June 11, 2015. He served on numerous public and private company boards in the biopharmaceutical industry. He served as a Director of Omthera Pharmaceuticals, Inc. from April 2011 to July 18, 2013. He served as a Director of Zosano Pharma Corporation, MdBio, Inc., and of Maryland Tech Council. He served as a Director of Melinta Therapeutics, Inc. until September 2008 and also served as its Independent Director. He served as a Director of Ambit Pharmaceuticals and Rib-X Pharmaceuticals. He served as a Director of Ambit Biosciences Corporation since November 2007. He served as a Director of MedImmune, LLC from November 1995 to June 1, 2007. He served as a Non-Executive Director of Shire plc from October 31, 2007 to October 30, 2009. Mr. Mott holds a B.A. degree in Economics and Government from Dartmouth College.Read Full Background




Corporate Headquarters
840 Memorial DriveCambridge, Massachusetts 02139United StatesPhone: 617-498-0020Fax: --
Board Members Memberships
DirectorBiotechnology Innovation OrganizationExecutive Chairman3-V Biosciences, Inc.DirectorSt Albans SchoolDirectorEdimer Pharmaceuticals Inc.Member of the Board of DirectorsNightstaRx LimitedBoard ChairVtesse, Inc.ChairmanImara, Inc.2009-PresentChairman of the BoardEpizyme, Inc.2009-PresentChairmanArdelyx, Inc.2010-PresentChairmanTesaro, Inc.2012-PresentExecutive ChairmanMersana Therapeutics, Inc.2015-PresentChairman of the Board of DirectorsAdaptimmune Therapeutics plc2015-PresentDirectorXTuit Pharmaceuticals, Inc.2015-PresentDirectorClementia Pharmaceuticals Inc.
Education
BA Dartmouth College
Other Affiliations
New Enterprise AssociatesMedImmune LimitedAstraZeneca PLCShire plcCitigroup CIBAmbit Biosciences CorporationMedImmune, LLCMelinta Therapeutics, Inc.MdBio, Inc.MedImmune Ventures, Inc.Dartmouth CollegeBiotechnology Innovation OrganizationBioMarin Nederland B.V.Conceptis Technologies, Inc.Maryland Tech CouncilZosano Pharma Corporation3-V Biosciences, Inc.St Albans SchoolThe Royal Institute of International AffairsScripps Translational Science Institute (stsi)Epizyme, Inc.Ardelyx, Inc.Zyngenia, Inc.Omthera Pharmaceuticals, Inc.Edimer Pharmaceuticals Inc.Tesaro, Inc.Adaptimmune Therapeutics plcXTuit Pharmaceuticals, Inc.New Enterprise Associates 14, L.P.Clementia Pharmaceuticals Inc.NightstaRx LimitedVtesse, Inc.Imara, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Mersana Therapeutics, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























David Mott | NEA | New Enterprise Associates








Skip to Navigation
Skip to Content






About

Portfolio

Companies
Resources
Talent
Technology Briefings
Programs & Events


Team
History
News
Contact

Login





See our Facebook



See our Twitter



See our LinkedIn




Search








Search

Search




NEA


return home



Toggle Nav








David Mott

										General Partner, Washington DC
									

Healthcare
Biopharma






















Bio
Writing
Speaking
News





Dave Mott joined New Enterprise Associates in September 2008 as a General Partner and leads the healthcare investing practice, which typically comprises roughly one-third of each fund, or $1 billion of healthcare venture investments every three years. NEA is a leading investor across all healthcare sub-sectors, including biopharma, medical technology, and healthcare services, and invests across all stages and geographies.  Dave’s personal investing practice is primarily focused on biopharmaceutical investments. Prior to joining NEA, Dave was President and Chief Executive Officer of MedImmune, subsidiary of AstraZeneca Plc, and Executive Vice President of AstraZeneca. Dave joined MedImmune in 1992 and served in various roles including, from October 2000 through June 2008, president and chief executive officer, and previously chief financial officer, and president and chief operating officer. He led the sale of MedImmune to AstraZeneca in June 2007 for $15.6 billion. In 2002, Dave founded MedImmune Ventures and chaired its investment committee through his departure from MedImmune. At the time of his departure in July 2008, MedImmune had annual revenues in excess of $1.5 billion, annual R&D in excess of $650 million and approximately 3,000 employees. Prior to joining MedImmune, Dave was a Vice President in Health Care Investment Banking at Smith Barney, Harris Upham & Co., Inc. where he focused on public and private equity and debt financings as well as mergers and acquisitions. He received a bachelor of arts degree in economics and government from Dartmouth College.
           Dave is currently Chairman of 3-V Biosciences, Adaptimmune (NASDAQ: ADAP), Ardelyx (NASDAQ: ARDX), Cydan, Epizyme (NASDAQ: EPZM), Imara, Mersana, and TESARO (NASDAQ: TSRO), and is a director of Clementia, NightstaRx, and Xtuit.  He has previously been a director of Ambit Pharmaceuticals, Conceptis, Edimer, MedImmune, Omthera Pharmaceuticals, Prosensa, Rib-X Pharmaceuticals, Shire Pharmaceuticals, and Zyngenia.







																		Bullish on Boston: Why Biotech (and more) is Booming
																		
																			NEA Blog










																		Dave Mott Panelist on the Redefining Venture Capital Panel at Biotechnologia 2015
																	



																		Dave Mott to Speak at BioTrinity 2014 Conference
																	



																		David Mott to speak at Dartmouth Ventures Conference
																	








June 6, 2016


																			Where the money is: The top 100(+) VCs investing in U.S. biotechs
																			
																				Endpoints News 



July 1, 2015


																			New Enterprise Flies Higher
																			
																				START-UP



March 11, 2017


																			NEA Venture Partner Scott Gottlieb, M.D., Nominated to be FDA Commissioner
																			
																		


October 27, 2015


																			NEA Promotes Sara Nayeem, M.D. to Partner
																			
																		


September 25, 2014


																			Adaptimmune Secures $104 Million in Series A Financing
																			
																		


January 9, 2014


																			Elliott Sigal Joins NEA as Venture Partner and Senior Advisor
																			
																		


November 14, 2013


																			NEA Opens Boston Office to Serve Growing Portfolio, Pursue New Investments
																			
																		


June 20, 2013


																			Kurma Life Sciences Partners Raises €44M for New Fund
																			
																		


April 11, 2013


																			Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors
																			
																		













Companies


All


Current


Boards


IPOs


Acquisitions




Adaptimmune


3-V Biosciences


Ardelyx


Clementia


Cydan


Edimer Pharmaceuticals


Epizyme


Imara


Mersana


NightstaRx


Omthera Pharmaceuticals


Prosensa


Tesaro


Vtesse


Xtuit









News and Media
Limited Partner Login
Employee Loginopens in new window
Portfolio Company Login
Contact Us




See our Facebook



See our Twitter



See our LinkedIn




Copyright 2017
NEA Terms & Conditions
Privacy Policy




























David M. Mott - Imara































Sign up for Email updates













David M. Mott


 


David M. Mott
General Partner, New Enterprise Associates

Dave Mott joined New Enterprise Associates in September 2008 as a General Partner primarily focused on biopharmaceutical investments. Dave leads NEA’s healthcare investing practice which typically comprises 30% to 40% of each fund, or roughly $750 million to $1 billion of healthcare venture investments every three to four years. The firm invests across all stages and geographies and is a leading investor across all healthcare sectors.
Prior to joining NEA, Dave was President and Chief Executive Officer of MedImmune, subsidiary of AstraZeneca Plc, and Executive Vice President of AstraZeneca. Dave joined MedImmune in 1992 and served in roles of increasing responsibility including Chief Operating Officer, Chief Financial Officer, President and from 2000 – 2008 Chief Executive Officer as the company grew from a venture-backed startup (founded in 1988) into one of the top five biotechnology companies in the world. Ultimately, he led the sale of MedImmune to AstraZeneca in June 2007 for $15.6 billion. In 2002, Dave founded MedImmune Ventures and chaired its investment committee through his departure from MedImmune. At the time of his departure in July 2008, MedImmune had annual revenues in excess of $1.5 billion, annual R&D in excess of $650 million and approximately 3,000 employees. Prior to joining MedImmune, Dave was a Vice President in Health Care Investment Banking at Smith Barney, Harris Upham & Co., Inc. where he focused on public and private equity and debt financings as well as mergers and acquisitions. He received a bachelor of arts degree in economics and government from Dartmouth College.
Dave is currently Chairman of 3-V Biosciences, Ardelyx, Cydan, Mersana, Prosensa, TESARO, and Zyngenia and is a director of Adaptimmune, Edimer Pharmaceuticals, and Epizyme.  He has previously been a director of MedImmune, Shire Pharmaceuticals, Ambit Pharmaceuticals, Omthera Pharmaceuticals, Rib-X Pharmaceuticals and Conceptis.




 









ARDX David M. Mott Insider Trades for Ardelyx Inc.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Ardelyx Inc.

                  NASDAQ: ARDX
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Ardelyx Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:33 p.m.


ARDX

/quotes/zigman/34042469/composite


$
5.60




Change

-0.0011
-0.02%

Volume
Volume 4,150
Quotes are delayed by 20 min








/quotes/zigman/34042469/composite
Previous close

$
			5.50
		


$
				5.60
			
Change

+0.10
+1.82%





Day low
Day high
$5.40
$5.80










52 week low
52 week high

            $4.05
        

            $16.30
        


















Insider Activity


Individual




David M. Mott



Mr. Dave M. Mott is Independent Non-Executive Director at Adaptimmune Therapeutics Plc, Chairman at Mersana Therapeutics, Inc., Chairman at TESARO, Inc., Independent Director at Epizyme, Inc., Chairman at Ardelyx, Inc., General Partner at New Enterprise Associates LLC, Chairman at Zyngenia, Inc., Chairman at 3-V Biosciences, Inc., Chairman at Cydan LLC, and Chairman at Vtesse, Inc. He is on the Board of Directors at Adaptimmune Therapeutics Plc, Adaptimmune Ltd., Epizyme, Inc., Biotechnology Industry Organization, St. Albans School, Edimer Pharmaceuticals, Inc., and NEA 14 GP Ltd.
Mr. Mott was previously employed as Chairman-Supervisory Board by Prosensa Holding NV, Non-Executive Director by Shire Plc, President by MedImmune Ventures, Inc., President, Chief Executive Officer & Director by MedImmune LLC, Chairman by Conceptis Technologies, Inc., Executive Vice President by AstraZeneca Plc, a Trustee by St. James' School, Vice President-Health Care Investment Banking by Smith Barney Harris Upham & Co., Inc., and VP-Health Care Investment Banking Group by Harris Upham & Co, Inc. He also served on the board at Omthera Pharmaceuticals, Inc., Shire Plc, Ambit Biosciences Corp., Melinta Therapeutics, Inc., Shire Pharmaceuticals, Inc., Zosano Pharma Corp., and ZP Opco, Inc.
He received his undergraduate degree from Dartmouth College.



Transactions


Date
Shares
Transaction
Value








        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Michael G. Raab 
President, Chief Executive Officer & Director




Dr. Reginald  Seeto 
Chief Operating Officer




Mr. Mark E. Kaufmann 
Chief Financial Officer & Treasurer




Dr. Jeremy S. Caldwell 
Chief Scientific Officer & Executive VP




Dr. Paul  Korner 
Chief Medical Officer & Executive Vice President




Dr. Jeffrey W. Jacobs 
Senior Vice President-Technical Operations




Mr. George T. Jue 
Vice President-Finance & Operations




Dr. David P. Rosenbaum 
Vice President-Drug Development




Mr. Bryan  Shaw 
Chief Accounting Officer & VP-Corporate Controller




Ms. Elizabeth  Grammer 
Senior Vice President & General Counsel




Mr. Robert C. Blanks 
VP-Regulatory Affairs & Quality Assurance




Mr. David M. Mott 
Chairman




Mr. Robert B. Bazemore 
Independent Director




Dr. Gordon  Ringold 
Independent Director




Mr. William C. Bertrand 
Independent Director




Mr. Richard J. Rodgers 
Independent Director




Dr. Annalisa  Jenkins 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




8:27 AM EDT
July 22, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:21aStocks brace for volatility in earnings deluge; Fed meeting looms 
8:15a9 charts that capture how the rest of the world feels about Donald Trump
6:00a4 questions you should never answer at work
6:00aThe shocking amount guests now have to spend to attend a wedding
8:34pCharges dropped after ‘London Whale’ accused Jamie Dimon of making him a fall guy
7:41pGoodbye, Sean Spicer: Memorable Moments From the Podium  
7:18pHow to Fix Wall Street, and Bankers' Pay
6:59pAmazon, Whole Foods look to head off lengthy deal review
6:45pHawaii adopts emergency plan for North Korea missile attack
6:24p California Wildfire Destroys Homes Near Yosemite
6:20pSpicer Quits as Scaramucci Accepts White House Job
6:20pWhy you shouldn’t order ice on a flight, and other ‘dirty little secrets’ 
6:09pIf you’re reading this, you have a 19.3% chance of being rich
6:07p5 unfortunate reasons why millennials can’t have nice things (or save any money)
6:06pThis is the deadliest time of your life to put on weight
6:06pIf, like Sean Spicer, you suddenly walk out — what should you do next?
5:37pA History of Sears: Through Highs and Lows
5:13pAre you a money bully?
5:10pHow real-estate TV shows determine what home buyers look for and what to do if you decide to quit your job like Sean Spicer
5:07pBREAKINGWall Street's 'fear gauge'--the VIX--just logged its second-lowest close in history
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































 


David Mott | Professional Profile
 


























 









LinkedIn



















































Main content starts below.




David MottVice President & General CounselLocationGreater New York City AreaIndustryMedical DevicesCurrentParkell, Inc. (global medical device company)PreviousForest Laboratories, Inc. (a global pharmaceutical company, acquired by Allergan/Actavis in 2014), Jones Day, Mayer, Brown, Rowe & Maw LLPEducationThe George Washington University Law School364 connectionsView David’s full profile. It's free!Your colleagues, classmates, and 500 million other professionals are on LinkedIn.View David’s Full ProfileExperienceGeneral Counsel;  Vice President, Intellectual Property & Regulatory AffairsParkell, Inc. (global medical device company)July 2014  –  Present (3 years 1 month)Manage legal, regulatory & compliance teams.  As member of executive management team, I counsel board of directors, executives & all global teams.  Negotiate and draft all forms of corporate agreements (acquisition, patent license, private label, virtual manufacturer, supply, quality agreements, etc.).  Draft & prosecute new product registrations with the FDA and foreign health organizations.  Perform all patent and trademark analyses (freedom-to-operate, patentability, etc.); manage outside counsel when utilized.  Manage global compliance, regulatory & QA, and internal/external audit teams, etc. to ensure corporate compliance with all Quality System (21 CFR 820, ISO 13485:2016, and the like), product registration, product marketing & labeling, import/export, employee safety, and other regulations & standards.  Participate in all external audits (FDA, Notified Body, TUV, etc.).Director, Patent CounselForest Laboratories, Inc. (a global pharmaceutical company, acquired by Allergan/Actavis in 2014)October 2008  –  July 2014 (5 years 10 months)AssociateJones DayJuly 2006  –  October 2008 (2 years 4 months)AssociateMayer, Brown, Rowe & Maw LLPJuly 2005  –  July 2006 (1 year 1 month)Registered Patent AgentLeydig, Voit & Mayer, Ltd.1998  –  2001 (3 years)Chemical Research TechnicianMonsanto1997  –  1998 (1 year)OrganizationsNYIPLASuffolk County Bar AssociationNYSBARAPSSkillsLicensingDue DiligenceIntellectual PropertyPatentsRegulatory AffairsLitigationTechnology TransferHow's this translation?Great•Has errorsThanks for your help!EducationThe George Washington University Law SchoolJuris DoctorJuris Doctor2001  –  2004Northwestern UniversityMaster of Science (M.S.)Master of Science (M.S.)1998  –  2000Trinity College-HartfordBachelor of Science (B.S.)Bachelor of Science (B.S.)1992  –  1996View David’s full profile to...See who you know in commonGet introducedContact David directlyView David’s Full ProfileNot the David you’re looking for? View moreView this profile in another languageEnglishGermanChinese (Simplified)People Also ViewedOlimpia JakubowskaIntellectual Property Paralegal/ Fashion DesignerBryan YoonSenior Vice President -- Legal Affairs at Intercept PharmaceuticalsLoretta M.Mediation and Legal ProfessionalChristopher BeckChief IP Counsel at Sciex and Molecular DevicesMichael TaussiAttorney at Intercept Pharmaceuticals, Inc.Ryan ZackDirector of Advertising and Sales Operations at Panoply MediaPeter GouldManaging Partner, Denver Office at Squire Patton BoggsJoseph LerchPrincipal at Joseph B. Lerch Law OfficeAnne Marie ChecconePublic profile badgeInclude this LinkedIn profile on other websitesView profile badgesFind a different David MottFirst NameLast NameExample:  David MottDavid MottGeneral Partner at New Enterprise AssociatesUnited StatesDavid MottSr. iOS Engineer at Stealth Mode Startup CompanyUnited StatesDavid MottTax Technology ProfessionalUnited StatesDavid MottExecutive Vice President, Willis Towers WatsonUnited StatesDavid MottDirector at ContinentalUnited StatesMore professionals named David MottLinkedIn member directory:abcdefghijklmnopqrstuvwxyzmoreBrowse members by country




















   Edward Mott | Oxford Capital Partners Limited | ZoomInfo.com

DAVID M  MOTT - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











DAVID M  MOTT
Check out list of companies and businesses related to DAVID M  MOTT. Find out DAVID M  MOTT address and contact details. View other people related to DAVID M  MOTT - coworkers, colleagues, companions, etc.
Address:   

35 WEST WATKINS MILL ROAD  GAITHERSBURG 20878 MD




Companies related to DAVID M  MOTT
CIKCompany NamePositionCompany Address0000771856CHAMPIONS ONCOLOGY, INC.855 N. WOLFE STREET SUITE 619 BALTIMORE 212050000873591MEDIMMUNE INC /DEVice Chairman and CEO ONE MEDIMMUNE WAY  GAITHERSBURG 208780000907654ARCA biopharma, Inc.11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER 800200001037649INTERLEUKIN GENETICS INC10% Owner 135 BEAVER ST  WATHAM 024520001301501Achaogen Inc10% Owner 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO 940800001325879AVEO PHARMACEUTICALS INC10% Owner ONE BROADWAY 14TH FLOOR CAMBRIDGE 021420001374684MULESOFT, INC10% Owner 77 GEARY ST. SUITE 400 SAN FRANCISCO 941080001394319Tracon Pharmaceuticals, Inc.10% Owner 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego 921220001412067Cascadian Therapeutics, Inc.2601 FOURTH AVENUE SUITE 500 SEATTLE 981210001437402ARDELYX, INC.Director 34175 ARDENWOOD BLVD.  FREMONT 945550001441683APPIAN CORP10% Owner 11955 DEMOCRACY DRIVE SUITE 1700 RESTON 201900001442836Mersana Therapeutics, Inc.Director 840 MEMORIAL DRIVE  CAMBRIDGE 021390001472343Roka BioScience, Inc.10% Owner 20 INDEPENDENCE BOULEVARD  WARREN 070590001481512Ra Pharmaceuticals, Inc.10% Owner 87 CAMBRIDGE PARK DRIVE  CAMBRIDGE 021400001491576TESARO, Inc.Director 1000 WINTER STREET, SUITE 3300  WALTHAM 024510001527599Mirna Therapeutics, Inc.10% Owner 3711 SOUTH MOPAC EXPRESSWAY, STE 100  AUSTIN 787460001534120Cerecor Inc.10% Owner 400 E. PRATT ST. SUITE 606 BALTIMORE 212020001571498Epizyme, Inc.Director 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE 021390001621227Adaptimmune Therapeutics PLCDirector 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE OX14 4RY




DAVID M  MOTT on the Web
Persons related to DAVID M  MOTT - CHAMPIONS ONCOLOGY, INC.NamePositionCityPoliakoff  AbbaBaltimorePoliakoff  AbbaHackensackPoliakoff  AbbaHackensackPoliakoff  AbbaHackensackJOEL  ACKERMANChief Executive Officer NEW YORKJOEL  ACKERMANChief Executive Officer NEW YORKJOEL  ACKERMANBALTIMORENeeraj  AgrawalWALTHAMNeeraj  AgrawalWALTHAMStancic  AnaBaltimoreStancic  AnaHackensackStancic  AnaHackensackEpker,  Arthur IIIHackensackM JAMES  BARRETTBALTIMOREPETER J  BARRISBALTIMOREFOREST  BASKETTBALTIMOREBattery Investment Partners IX, LLCWALTHAMBattery Partners IX, LLCWALTHAMBattery Ventures IX, L.P.10% Owner WALTHAMPhilip P.  BreitfeldDirector HACKENSACKMICHAEL MAURICE  BROWN10% Owner WELLESLEYMICHAEL MAURICE  BROWN10% Owner WALTHAMDOUGLAS D  BURKETTPresident CHANDLERCHAMPIONS SPORTS INCChairman, President and CEO ARLINGTONTHOMAS J  CROTTYSAN MATEOTHOMAS J  CROTTYWALTHAMMendelson  DanielHackensackMiller  DavidHackensackSidranksky  DavidHackensackSidransky  DavidHackensackSidransky  DavidHackensackSidransky, M.D.  DavidBaltimoreSidransky, M.D.  DavidHackensackBurkett, Ph.D.  DouglasBaltimoreRYAN D  DRANTBALTIMOREArthur G  Epker IIIHACKENSACKArthur G  Epker IIIDirector HACKENSACKJesse  FeldmanBOSTONAnthony A. Jr.  FlorenceCHEVY CHASERICHARD D  FRISBIESAN MATEORICHARD D  FRISBIEWALTHAMGemignani  GaryHackensackManuel  HidalgoBALTIMOREMartell  JamesBaltimoreMartell  JamesHackensackMcGorry  JamesHackensackAckerman  JoelBaltimoreAckerman  JoelHackensackAckerman  JoelHackensackPATRICK J  KERINSBALTIMOREKRISHNA KITTU  KOLLURIBALTIMOREKENNETH P  LAWLERSAN MATEOKENNETH P  LAWLERWALTHAMRoger H  LeeWALTHAMRoger H  LeeWALTHAMSchonau  MarkBaltimoreJames  MartellDirector ARLINGTONJames  MartellDirector BALTIMOREJames  MartellDirector BALTIMOREDaniel Newman  MendelsonDirector WASHINGTONDaniel Newman  MendelsonDirector HACKENSACKDaniel Newman  MendelsonHACKENSACKDaniel Newman  MendelsonDirector HACKENSACKDAVID BARRY  MILLERVice President, Finance TEANECKRonnie  MorrisPresident BALTIMORERonnie  MorrisPresident HACKENSACKDAVID M  MOTTGAITHERSBURGNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.TIMONIUMPAR CAPITAL MANAGEMENT INCBOSTONPAR Group, L.P.BOSTONPAR INVESTMENT PARTNERS LPBOSTONAbba David  PoliakoffDirector BALTIMOREAbba David  PoliakoffDirector ARLINGTONAbba David  PoliakoffDirector BALTIMOREAbba David  PoliakoffDirector HACKENSACKMorris  RonnieHackensackMorris  RonnieHackensackMorris, M.D.  RonnieBaltimoreMorris, M.D.  RonnieHackensackSCOTT D  SANDELLBALTIMOREMark  SchonauChief Financial Officer CHANDLERMark  SchonauCFO BALTIMOAREMark  SchonauAccting PEO and CFO BALTIMORETobin  ScottHackensackTobin  ScottHackensackTobin  ScottHackensackDurwood  SettlesDirector ARLINGTONDAVID  SIDRANSKYDirector NEW YORKDAVID  SIDRANSKYDirector HACKENSACKDAVID  SIDRANSKY10% Owner BALTIMOREDAVID  SIDRANSKYDirector BALTIMOREPeter W.  SonsiniMENLO PARKAna  StancicDirector BALTIMOREAna  StancicDirector NEW YORKAna  StancicARLINGTONAna  StancicDirector ARLINGTONAna  StancicDirector BALTIMORER DAVID  TABORSWALTHAMR DAVID  TABORSWALTHAMSCOTT R  TOBINDirector WELLESLEYSCOTT R  TOBINDirector HACKENSACKSCOTT R  TOBINDirector BOSTONSCOTT R  TOBINWALTHAMSCOTT R  TOBINWALTHAMRavi  ViswanathanTIMONIUMHarry R  WellerBALTIMOREPersons related to DAVID M  MOTT - MEDIMMUNE INC /DENamePositionCityARMANDO  ANIDOEVP, Sales & Marketing GAITHERSBURGARMANDO  ANIDOSVP, Commerical Operations GAITHERSBURGARMANDO  ANIDOEVP, Sales and Marketing GAITHERSBURGARMANDO  ANIDOEVP, Sales and Mktg GAITHERSBURGDAVID  BALTIMOREDirector GAITHERSBURGDAVID  BALTIMOREDirector M JAMES  BARRETTDirector GAITHERSBURGM JAMES  BARRETTDirector BALTIMOREWilliam C  Bertrand JRSVP, General Counsel, Sec GAITHERSBURGMELVIN D  BOOTHDirector GAITHERSBURGJAMES H  CAVANAUGHDirector PrincetonEDWARD M  CONNORSVP and Chief Medical Officer GAITHERSBURGEDWARD M  CONNORExecutive VP, CMO GAITHERSBURGEDWARD M  CONNOREVP Clin. Dev., CMO GAITHERSBURGGail M  Folena-WassermanGAITHERSBURGGail M  Folena-WassermanSVP, Development GAITHERSBURGPeter  GreenleafSVP, Sales and Marketing GAITHERSBURGFRANKLIN BARBARA  HACKMANDirector GAITHERSBURGFRANKLIN BARBARA  HACKMANDirector HARTFORDWAYNE T  HOCKMEYERChairman of the Board, Pres. GAITHERSBURGWAYNE T  HOCKMEYERChairman GAITHERSBURGWAYNE T  HOCKMEYERChairman/Pres. MedI Ventures GAITHERSBURGROBERT H  HOTZDirector GAITHERSBURGPeter A  KienerGAITHERSBURGPeter A  KienerSVP, Research GAITHERSBURGPamela J  LupienSVP, Human Resources GAITHERSBURGPamela J  LupienSVP, Human Resources GAITHERSBURGBernardus N M  MachielseEVP, Operations GAITHERSBURGBernardus N M  MachielseEVP, Operations GAITHERSBURGGORDON S  MACKLINDirector GAITHERSBURGGORDON S  MACKLINDirector SAN MATEOEdward T  MathersEVP, Corporate Dev. & Venture GAITHERSBURGEdward T  MathersExec.VP, Corp. Dev. & Ventures GAITHERSBURGSidney  MazelSVP, Product Planning GAITHERSBURGGEORGE M  MILNE JRDirector GAITHERSBURGGEORGE M  MILNE JRDirector DAVID M  MOTTVice Chairman and CEO GAITHERSBURGDAVID M  MOTTVice Chair. of the Board, CEO GAITHERSBURGDAVID M  MOTTVice Chairman, CEO & President GAITHERSBURGDAVID M  MOTTVice Chairman, CEO & President GAITHERSBURGLinda J  PetersGAITHERSBURGLinda J  PetersSVP, Regulatory Affairs GAITHERSBURGRichard Michael  SmullenSVP, Sales GAITHERSBURGMark E  SpringVP, Finance and Controller GAITHERSBURGELIZABETH H S  WYATTDirector ELIZABETH H S  WYATTDirector GAITHERSBURGJAMES F  YOUNGPresident, R&D GAITHERSBURGJAMES F  YOUNGPresident, R&D GAITHERSBURGJAMES F  YOUNGPresident, R&D GAITHERSBURGJAMES F  YOUNGGAITHERSBURGLOTA S  ZOTHChief Financial Officer GAITHERSBURGLOTA S  ZOTHSVP, Chief Financial Officer GAITHERSBURGLOTA S  ZOTHSVP & CFO GAITHERSBURGPersons related to DAVID M  MOTT - ARCA biopharma, Inc.NamePositionCityAtlas Venture Associates VII, L.P.WALTHAMAtlas Venture Associates VII, L.P.CAMBRIDGEAtlas Venture Fund VII L PWALTHAMAtlas Venture Fund VII L P10% Owner WALTHAMAtlas Venture Fund VII L PCAMBRIDGEPETER J  BARRISBALTIMOREFOREST  BASKETTBALTIMOREE LEE  BENDEKGEYSr VP CFO & General Counsel SUNNYVALEE LEE  BENDEKGEYSr VP & General Counsel SAN CARLOSE LEE  BENDEKGEYSr. VP CFO and General Counsel SAN CARLOSE LEE  BENDEKGEYSAN CARLOSBOULDER VENTURES IV ANNEX LP10% Owner BOULDERBOULDER VENTURES IV LPBOULDERRICHARD B  BREWERDirector BROOMFIELDRICHARD B  BREWERDirector BROOMFIELDSelby  BrianWestminsterMICHAEL R  BRISTOWPres. & Chief Executive Offic WESTMINSTERMICHAEL R  BRISTOWBROOMFIELDMICHAEL R  BRISTOWPresident and CEO BROOMFIELDMICHAEL R  BRISTOWPresident and CEO BROOMFIELDMICHAEL R  BRISTOWPresident and CEO BROOMFIELDMICHAEL R  BRISTOWPres & CEO MICHAEL R  BRISTOWPresident and CEO WESTMINSTERSobel  BurtonBroomfieldSobel  BurtonBroomfieldBV PARTNERS IV, L.L.C.BOULDERPHILIPPE  CHAMBONDirector SUNNYVALEOzeroff  ChristopherBroomfieldOzeroff  ChristopherBroomfieldOzeroff  ChristopherWestminsterOzeroff  ChristopherWestminsterROBERT  CONWAYDirector BOULDERROBERT E  CONWAYBROOMFIELDROBERT E  CONWAYDirector BROOMFIELDROBERT E  CONWAYDirector WESTMINSTERSUISSE FIRST BOSTON/  CREDIT NEW YORKMitchell  DanWestminsterKATHRYN E  FALBERGCFO and COO LARKSPURJosh E  FidlerBOULDERLINDA A  FITZPATRICKSenior V.P. of Human Resources SUNNYVALEAnthony A. Jr.  FlorenceCHEVY CHASEJEAN FRANCOIS  FORMELADirector CAMBRIDGEJEAN FRANCOIS  FORMELADirector CAMBRIDGEJEAN FRANCOIS  FORMELASUNNYVALEJEAN FRANCOIS  FORMELADirector WALTHAMJEAN FRANCOIS  FORMELADirector WALTHAMJ WILLIAM  FREYTAGDirector NIWOTPETER S  GARCIASenior V.P. and C.F.O. SUNNYVALEJAMES R  GAVIN IIIDirector SAN CARLOSLinda S  GraisDirector MENLO PARKLinda S  GraisDirector MENLO PARKLinda S  GraisDirector MENLO PARKLinda S  GraisDirector BROOMFIELDLinda S  GraisDirector WESTMINSTERGrowth Equity Opportunities IV, LLCTIMONIUMAnders D  HoveDirector NEW YORKFreytag  J.BroomfieldFormela  Jean-FrancoisBroomfieldFormela  Jean-FrancoisBroomfieldZabriskie  JohnBroomfieldZabriskie  JohnBroomfieldANDREW E  JONESBOULDERFalberg  KathrynBroomfieldThomas A  KeuerChief Operating Officer GLEN ALLENThomas A  KeuerWESTMINSTERThomas A  KeuerChief Operating Officer WESTMINSTERBong Y  KohPALO ALTOKRISHNA KITTU  KOLLURIBALTIMOREKYLE  LEFKOFFBOULDERMICHAEL D  LEVYSr. VP Research & Development SUNNYVALEMICHAEL D  LEVYSr. VP Research & Development SAN CARLOSMICHAEL D  LEVYExecutive Vice President SAN CARLOSGrais  LindaBroomfieldGrais  LindaBroomfieldGrais  LindaWestminsterGrais  LindaWestminsterTED W  LOVEPresident and C.E.O. SUNNYVALETED W  LOVEC.E.O. SAN CARLOSTED W  LOVEC.E.O. SAN CARLOSTED W  LOVEDirector BROOMFIELDDavid George  LoweDirector PALO ALTODavid George  LoweDirector PALO ALTOLawrence M  MacksBOULDERJOSHUA  MAKOWERPendergast  MaryBroomfieldCARTER THOMAS N  MC IIISUNNYVALEriley  mccormack10% Owner CORAL GABLESriley  mccormack10% Owner CORAL CABLESBristow  MichaelBroomfieldBristow  MichaelBroomfieldBristow  MichaelWestminsterBristow  MichaelWestminsterDANIEL J  MITCHELLDirector BOULDERDANIEL J  MITCHELLDirector WESTMINSTERDAVID M  MOTTGAITHERSBURGNEA 15 GP, LLCTIMONIUMNEA Partners 15, L.P.TIMONIUMNew Enterprise Associates 15, L.P.TIMONIUMChristopher David  OzeroffS.V.P., General Counsel BROOMFIELDChristopher David  OzeroffSVP and General Counsel BROOMFIELDChristopher David  OzeroffSVP and General Counsel BROOMFIELDChristopher David  OzeroffS.V.P., General Counsel BROOMFIELDChristopher David  OzeroffS.V.P., General Counsel WESTMINSTERWheeler  PatrickBroomfieldWheeler  PatrickWestminsterMARY K  PENDERGASTDirector SUNNYVALEMARY K  PENDERGASTDirector SAN CARLOSMARY K  PENDERGASTDirector WASHINGTONMARK L  PERRYDirector SUNNYVALEMARK L  PERRYDirector SAN CARLOSKimberly J  PopovitsDirector SUNNYVALEKimberly J  PopovitsDirector SAN CARLOSGEORGE B  RATHMANNDirector SUNNYVALEWoosley  RaymondWestminsterWoosley  RaymondWestminsterBrewer  RichardBroomfieldBrewer  RichardBroomfieldConway  RobertWestminsterConway  RobertWestminsterPeter  RoshkoBOULDERJon  SakodaTIMONIUMSCOTT D  SANDELLBALTIMOREBrian L.  SelbyVP, Finance WESTMINSTERBrian L.  SelbyVP, Finance WESTMINSTERSkyline Venture Partners Qualified Purchaser Fund IV L PPALO ALTOSkyline Venture Partners Qualified Purchaser Fund IV L P10% Owner PALO ALTOBURTON E  SOBELDirector SAN CARLOSBURTON E  SOBELDirector BROOMFIELDBURTON E  SOBELDirector BROOMFIELDBURTON E  SOBELDirector SUNNYVALEBURTON E  SOBELDirector SAN CARLOSPeter W.  SonsiniMENLO PARKLaurent Randall  StBROOMFIELDLove  TedBroomfieldKeuer  ThomasWestminsterGary  TitusVP Finance, Chief Acct.Officer SUNNYVALEGary  TitusChief Acct.Officer SAN CARLOSVenrock Healthcare Capital Partners II, L.P.PALO ALTOVENROCK HEALTHCARE CAPITAL PARTNERS LPPALO ALTOVHCP Co-Investment Holdings II, LLCPALO ALTOVHCP Co-Investment Holdings, LLCPALO ALTOVHCP Management II, LLCPALO ALTOVHCP Management, LLCPALO ALTORavi  ViswanathanTIMONIUMHarry R  WellerBALTIMOREPatrick M  Wheeleracting Chief Financial Officer BROOMFIELDPatrick M  WheelerChief Financial Officer BROOMFIELDPatrick M  WheelerChief Financial Officer BROOMFIELDPatrick M  WheelerChief Financial Officer WESTMINSTERHenry Ward  WolffSr. VP Finance and CFO SAN CARLOSRaymond L.  WoosleyDirector TUCSONRaymond L.  WoosleyDirector BROOMFIELDRaymond L.  WoosleyDirector WESTMINSTERJOHN L  ZABRISKIEDirector WELLESLEY HILLSJOHN L  ZABRISKIEBASALTJOHN L  ZABRISKIEDirector BASALTJOHN L  ZABRISKIEDirector BROOMFIELDBARRY L  ZUBROWDirector SUNNYVALEBARRY L  ZUBROWDirector SAN CARLOSPersons related to DAVID M  MOTT - INTERLEUKIN GENETICS INCNamePositionCityAlticor Global Holdings Inc.ADAALTICOR HOLDINGS INCADAALTICOR HOLDINGS INCADAALTICOR INCADAALTICOR INCADAGlenn S  ArmstrongWALTHAMM JAMES  BARRETT10% Owner BALTIMOREM JAMES  BARRETT10% Owner TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMBAY CITY CAPITAL FUND LLC10% Owner SAN FRANCISCOBay City Capital Fund V Co-Investment Fund, L.P.SAN FRANCISCOBay City Capital Fund V Co-Investment Fund, L.P.SAN FRANCISCOBay City Capital Fund V Co-Investment Fund LPSAN FRANCISCOBay City Capital Fund V, L.P.SAN FRANCISCOBay City Capital Fund V, L.P.SAN FRANCISCOBAY CITY CAPITAL LLCSAN FRANCISCOBAY CITY CAPITAL LLC10% Owner SAN FRANCISCOBay City Capital Management V LLCSAN FRANCISCOBay City Capital Management V LLCSAN FRANCISCOLEWIS H  BENDERWALTHAM, MASSACHUSETTSDianne E  BennettADAMark B  CarbeauCEO SAN ANTONIOLionel  CarnotWALTHAMEhrenberger  CatherineWalthamMARY E  CHOWNINGDirector WALTHAMMisfeldt  DaytonWalthamMisfeldt  DaytonWathamDelta Dental Plan of Michigan, Inc.10% Owner OKEMOSStephen J.  DiPalmaInterim CFO WORCESTERStephen J.  DiPalmaInterim CFO WALTHAMRYAN D  DRANT10% Owner TIMONIUMCatherine  EhrenbergerWALTHAMLurier  EliotWalthamFENEL M  ELOIChief Financial Officer WALTHAMDavid A  FinkelsteinWALTHAMAnthony A. Jr.  Florence10% Owner CHEVY CHASEAnthony A. Jr.  Florence10% Owner CHEVY CHASESTEPHEN A  GAROFALO10% Owner NEW CITYJurkovic  GoranWalthamGrowth Equity Opportunities Fund III, LLC10% Owner TIMONIUMWeaver  JamesWalthamWeaver  JamesWalthamWeaver  JamesWathamLandstra  JosephWalthamLandstra  JosephWathamGoran  JurkovicWALTHAMKornman  KennethWalthamKornman  KennethWathamPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMKENNETH S  KORNMANPresident and CSO WALTHAMKENNETH S  KORNMANSee Remarks WALTHAMJoseph M  LandstraADABender  LewisWalthamCarnot  LionelWalthamCarnot  LionelWathamEliot M  LurierChief Financial Officer WALTHAMCarbeau  MarkWathamChowning  MaryWalthamGregg Thomas  MayerWALTHAMJOHN J  MCCABEChief Accounting Officer WALTHAMWilliam C.  Mills IIIDirector CARLISLEWilliam C.  Mills IIIDirector WALTHAMDayton  MisfeldtWALTHAMRamon W MD  MohanlalWALTHAMDAVID M  MOTT10% Owner GAITHERSBURGDAVID M  MOTT10% Owner TIMONIUMNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.TIMONIUMPYXIS INNOVATIONS INC10% Owner ADAPYXIS INNOVATIONS INC10% Owner ADAPHILIP R  REILLYDirector WALTHAMTimothy J  RichersonWALTHAMColman  RogerWathamColman  RogerWalthamColman  RogerWalthamSCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMSnyder  ScottWalthamScott A.  SnyderChief Marketing Officer WALTHAMSOLSTICE HOLDINGS INCADAPeter W.  Sonsini10% Owner MENLO PARKDiPalma  StephenWalthamDiPalma  StephenWathamCurran  ThomasWalthamStephan  ToutainChief Commercial Officer WALTHAMRavi  Viswanathan10% Owner TIMONIUMWilliam J  Viveen JRADAJAMES M  WEAVERDirector GRANDVILLEJAMES M  WEAVERADAJAMES M  WEAVERDirector WALTHAMHarry R  Weller10% Owner BALTIMOREHarry R  Weller10% Owner TIMONIUMMills,  William IIIWalthamMills  William IIIWathamMills  WilliamWalthamMills  William IIIWalthamPersons related to DAVID M  MOTT - Achaogen IncNamePositionCityColowick  AlanSouth San FranciscoColowick  AlanSouth San FranciscoARCH VENTURE FUND VI LP10% Owner CHICAGOARCH VENTURE PARTNERS VI LLCCHICAGOARCH VENTURE PARTNERS VI LPCHICAGOPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREFilice  BeckiSouth San FranciscoKaren  BernsteinDirector FORT WASHINGTONDEREK A  BERTOCCIChief Financial Officer DEREK A  BERTOCCISVP and CFO SOUTH SAN FRANCISCOJAMES C  BLAIR10% Owner PRINCETONWise  BlakeSouth San FranciscoWise  BlakeSouth San FranciscoCHRISTOPHER S.  BOERNERDirector SOUTH SAN FRANCISCORoberts  BryanSouth San FranciscoROBERTS  BRYANPALO ALTORoberts  BryanSouth San FranciscoCLINTON  BYBEECHICAGOSamuels  CamilleMenlo ParkSamuels  CamilleSouth San FranciscoWelch  ChristineSouth San FranciscoWalsh  ChristopherSouth San FranciscoWalsh  ChristopherSouth San FranciscoAlan  ColowickDirector REDWOOD CITYKEITH  CRANDELLCHICAGOHom  DennisSouth San FranciscoDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONJOHN C  DOYLEDirector SOUTH SAN FRANCISCOJOHN C  DOYLEDirector SOUTH SAN FRANCISCODP VII ASSOCIATES LP10% Owner PRINCETONBecki  FiliceSOUTH SAN FRANCISCOMichael  FischbachDirector SOUTH SAN FRANCISCOAnthony A. Jr.  Florence10% Owner CHEVY CHASEIan  FriedlandSVP, Chief Medical Officer SOUTH SAN FRANCISCOLoeb  GarySouth San FranciscoHalley E  GilbertDirector CAMBRIDGEStea  GregorySouth San FranciscoStea  GregorySouth San FranciscoGrowth Equity Opportunities IV, LLC10% Owner TIMONIUMBrian K  Halak10% Owner PRINCETONGilbert  HalleySouth San FranciscoMoser  HeinzSouth San FranciscoKenneth  HillanChief Executive Officer SOUTH SAN FRANCISCODennis  HomSOUTH SAN FRANCISCOFriedland  IanSouth San FranciscoKevin  Judice  J.South San FranciscoDoyle  JohnSouth San FranciscoDoyle  JohnSouth San FranciscoDoyle  JohnSouth San FranciscoHollway  JohnSouth San FranciscoSmither  JohnSouth San FranciscoSmither  JohnSouth San FranciscoBruss  JonSouth San FranciscoHillan  KennethSouth San FranciscoHillan  KennethSouth San FranciscoNussbacher  KennethSouth San FranciscoLieginger  KentSouth San FranciscoLieginger  KentSouth San FranciscoKRISHNA KITTU  KOLLURI10% Owner BALTIMORESwem  LeeSouth San FranciscoKent  LiegingerDirector SOUTH SAN FRANCISCOGARY  LOEBGeneral Counsel EMERYVILLEJOSHUA  MAKOWER10% Owner Fischbach  MichaelSouth San FranciscoFischbach  MichaelSouth San FranciscoDAVID M  MOTT10% Owner GAITHERSBURGChristine  MurrayVP, Regulatory Affairs SOUTH SAN FRANCISCONEA 15 GP, LLCTIMONIUMNEA Partners 15, L.P.TIMONIUMROBERT  NELSENCHICAGONew Enterprise Associates 15, L.P.TIMONIUMMore  RobertSouth San FranciscoMore  RobertPalo AltoBRYAN E  ROBERTSDirector MENLO PARKBRYAN E  ROBERTSDirector PALO ALTOSCOTT M  ROCKLAGEDirector SOUTH SAN FRANCISCOJon  Sakoda10% Owner TIMONIUMCamille D  SamuelsDirector SOUTH SAN FRANCISCOSCOTT D  SANDELL10% Owner BALTIMOREZeryn  SarpangalSee Remarks SOUTH SAN FRANCISCOTobin  SchilkeChief Financial Officer SOUTH SAN FRANCISCOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONRocklage  ScottSouth San FranciscoRocklage  ScottMenlo ParkJohn W  SmitherDirector CALABASASJohn W  SmitherDirector SOUTH SAN FRANCISCOPeter W.  Sonsini10% Owner MENLO PARKGREGORY  STEADirector LEXINGTONLee  SwemSOUTH SAN FRANCISCOKing  ThomasSouth San FranciscoSchilke  TobinSouth San FranciscoJESSE I  TREU10% Owner PRINCETONCox  TroySouth San FranciscocVEF Management IV, LLCPALO ALTOVENROCK ASSOCIATES IV L P10% Owner PALO ALTOVENROCK ENTREPRENEURS FUND IV L PPALO ALTOVenrock Management IV, LLCPALO ALTOVenrock Partners, L.P.PALO ALTOVenrock Partners Management, LLCPALO ALTOVersant Affiliates Fund II-A, LPMENLO PARKVersant Side Fund II, LPMENLO PARKVersant Venture Capital II, LPMENLO PARKVersant Ventures II LLC10% Owner MENLO PARKRavi  Viswanathan10% Owner TIMONIUMNICOLE  VITULLO10% Owner PRINCETONCHRISTOPHER T PHD  WALSHDirector LEXINGTONCHRISTOPHER T PHD  WALSHDirector SOUTH SAN FRANCISCOWELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST10% Owner LONDONHarry R  WellerBALTIMOREBlake  WiseSee Remarks SOUTH SAN FRANCISCOSarpangal  ZerynSouth San FranciscoPersons related to DAVID M  MOTT - AVEO PHARMACEUTICALS INCNamePositionCityEvnin  AnthonyCambridgeEvnin  AnthonyCambridgeMICHAEL P  BAILEYPresident & CEO MICHAEL P  BAILEYChief Business Officer CAMBRIDGEMICHAEL P  BAILEYPresident & CEO CAMBRIDGEPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREKENNETH  BATEDirector CAMBRIDGE,KENNETH  BATEDirector CAMBRIDGEKENNETH  BATEDirector CAMBRIDGEDouglas G.  ColeDirector CAMBRIDGEMatthew D  DallasChief Financial Officer CAMBRIDGEJohnson  DavidCambridgeJohnston  DavidCambridgeRonald A  DePinhoDirector CAMBRIDGECole  DouglasCambridgeCole  DouglasCambridgeKeith S  EhrlichChief Financial Officer LEXINGTONEzickson  ElanCambridgeROBERT S  EPSTEINDirector CAMBRIDGEANTHONY B  EVNINDirector NEW YORKANTHONY B  EVNINDirector NEW YORKANTHONY B  EVNINDirector NEW YORKANTHONY B  EVNINDirector CAMBRIDGELUKE  EVNINBOSTONElan  EzicksonChief Operating Officer CAMBRIDGEAnthony A. Jr.  Florence10% Owner CHEVY CHASEANSBERT  GADICKEBOSTONNICHOLAS  GALAKATOSDirector BOSTONGrowth Equity Opportunities IV, LLC10% Owner TIMONIUMJeno  GyurisSVP, Chief Scientific Officer CAMBRIDGEJeno  GyurisSVP, Chief Scientific Officer CAMBRIDGENGOC TUAN  HADirector WOBURNNGOC TUAN  HAChief Executive Officer CAMBRIDGENGOC TUAN  HAChief Executive Officer CAMBRIDGETermeer  HenriCambridgeRUSSELL C  HIRSCHDirector CAMBRIDGEGyuris  JenoCambridgeDavid Brannon  JohnstonChief Financial Officer CAMBRIDGEMary Ellen  JonesSVP, Human Resources CAMBRIDGEVittiglio  JosephCambridgeBate  KenCambridgeBate  KennethCambridgeWeg  KennethCambridgeWeg  KennethCambridgeKRISHNA KITTU  KOLLURIBALTIMORERAJU S  KUCHERLAPATIDirector BOSTON,RAJU S  KUCHERLAPATIDirector CAMBRIDGERAJU S  KUCHERLAPATIDirector CAMBRIDGEJOSHUA  MAKOWER10% Owner Bailey  MichaelCambridgeDAVID M  MOTT10% Owner GAITHERSBURGMPM ASSET MANAGEMENT II LLCBOSTONMPM ASSET MANAGEMENT II LPBOSTONMPM ASSET MANAGEMENT INVESTORS 2002 BVII LLCBOSTONMPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KGBOSTONMPM BIOVENTURES II LPBOSTONMPM BIOVENTURES II QP LP BOSTONNEA 15 GP, LLCTIMONIUMNEA Partners 15, L.P.TIMONIUMMichael N  NeedleChief Medical Officer BOULDERMichael N  NeedleChief Medical Officer CAMBRIDGENew Enterprise Associates 15, L.P.TIMONIUMGalakatos  NicholasCambridgeGalakatos  NicholasCambridgeKucherlapati  RajuCambridgeKucherlapati  RajuCambridgeYoung  RobertCambridgeHiggins  RobertCambridgeMurray O.  RobinsonSVP, Translational Medicine CAMBRIDGEDePinho  RonaldCambridgeDePinho  RonaldCambridgeHirsch  RussellCambridgeHirsch  RussellCambridgeJon  Sakoda10% Owner TIMONIUMSCOTT D  SANDELL10% Owner BALTIMOREWilliam  SlichenmyerChief Medical Officer CAMBRIDGEWilliam  SlichenmyerChief Medical Officer CAMBRIDGEPeter W.  Sonsini10% Owner MENLO PARKMICHAEL  STEINMETZBOSTONHENRI A  TERMEERDirector HENRI A  TERMEERDirector CAMBRIDGEHENRI A  TERMEERDirector CAMBRIDGEHa-Ngoc  TuanCambridgeRavi  Viswanathan10% Owner TIMONIUMJoseph  VittiglioSVP & General Counsel CAMBRIDGEJoseph  VittiglioSVP, General Counsel CAMBRIDGEKENNETH E  WEGDirector CAMBRIDGEHarry R  WellerBALTIMOREKURT  WHEELERBOSTONSlichenmyer  WilliamCambridgeROBERT C  YOUNGDirector ROBERT C  YOUNGDirector CAMBRIDGEROBERT C  YOUNGDirector CAMBRIDGEPersons related to DAVID M  MOTT - MULESOFT, INCNamePositionCityAdage Capital Advisors, L.L.C.BOSTONADAGE CAPITAL PARTNERS GP LLC10% Owner BOSTONADAGE CAPITAL  PARTNERS LPWinblad  AnnSan FranciscoWinblad  AnnSan FranciscoRobert  AtchinsonBOSTONAU Special Investments, L.P.10% Owner OWINGS MILLSM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREBay Management Co XI LLC10% Owner PALO ALTOBay Partners XI L PPALO ALTOBAY PARTNERS XI PARALLEL FUND L PPALO ALTOGeorge  BischofPALO ALTOBROOKSIDE CAPITAL MANAGEMENT LLC10% Owner BOSTONBROOKSIDE CAPITAL PARTNERS FUND LPBOSTONBrookside Capital Trading Fund, L.P.BOSTONMark C.  BurtonDirector SAN FRANCISCOMICHAEL D  CAPELLASDirector ASHBURNCISCO SYSTEMS INC10% Owner SAN JOSESteven A  CollinsDirector INDIANAPOLISMark  DaoChief Product Officer SAN FRANCISCOBarry  EggersMENLO PARKAnthony A. Jr.  Florence10% Owner CHEVY CHASELittle  GaryMenlo ParkLittle  GarySan FranciscoMICHAEL B  GORDONGreenspring Associates, Inc.10% Owner OWINGS MILLSGreenspring FF-GP III, LLCOWINGS MILLSGreenspring Secondaries Fund I, L.P.10% Owner OWINGS MILLSGreenspring Secondaries Fund II, L.P.10% Owner OWINGS MILLSGreenspring Secondaries General Partner I, L.P.OWINGS MILLSGreenspring Secondaries General Partner II, L.P.OWINGS MILLSGreenspring Secondaries GP I, LLCOWINGS MILLSGreenspring Secondaries GP II, LLCOWINGS MILLSGreenspring SPV, LLCOWINGS MILLSSchott  GregSan FranciscoSchott  GregSan FranciscoSchott  GregSan FranciscoSchott  GregorySan FranciscoPhillip  GrossBOSTONRobert  HortonSVP People Ops, GC & Secretary REDWOOD CITYJohn  HummerSAN FRANCISCOHummer Winblad Equity Partners V, LLCSAN FRANCISCOHummer Winblad Equity Partners VI, L.L.C.SAN FRANCISCOHUMMER WINBLAD VENTURE PARTNERS V A LPSAN FRANCISCOHUMMER WINBLAD VENTURE PARTNERS V LP10% Owner SAN FRANCISCOHummer Winblad Venture Partners VI, L.P.SAN FRANCISCOPATRICK J  KERINS10% Owner BALTIMOREMITCHELL  KERTZMANSAN FRANCISCOMatt  LangdonChief Financial Officer SAN FRANCISCOJeremy  LiewMENLO PARKLightspeed General Partner Select, L.P.MENLO PARKLightspeed General Partner VII, L.P.MENLO PARKLightspeed Ultimate General Partner Select, Ltd.MENLO PARKLightspeed Ultimate General Partner VII, Ltd.MENLO PARKLightspeed Venture Partners Select, L.P.10% Owner MENLO PARKLightspeed Venture Partners VII, L.P.10% Owner MENLO PARKJames  LimOWINGS MILLSGary  LittleDirector PORTOLA VALLEYPAUL S  MADERANINO NIKOLA  MARAKOVICPALO ALTOBurton  MarkSan FranciscoBurton  MarkSan FranciscoBurton  MarkSan FranciscoRoss  Mason10% Owner SAN FRANCISCOLangdon  MatthewSan FranciscoMeritech Capital Affiliates IV L.P.PALO ALTOMeritech Capital Associates IV, L.L.C.10% Owner PALO ALTOMeritech Capital Partners IV L.P.PALO ALTORavi  MhatreDirector MENLO PARKDiFilippo  MichaelSan FranciscoDiFilippo  MichaelSan FranciscoMorgenthaler Management Partners VIII, LLCPORTOLA VALLEYMorgenthaler Partners VIII LP10% Owner PORTOLA VALLEYDAVID M  MOTT10% Owner GAITHERSBURGNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMCharles Ashton  NewhallOWINGS MILLSPeter  NiehMENLO PARKSimon  ParmettPresident, Field Operations SAN FRANCISCOSTUART G  PHILLIPSMhatre  RaviMenlo ParkMhatre  RaviSan FranciscoHorton  RobSan FranciscoHorton  RobertSan FranciscoMason  RossSan FranciscoMason  RossSan FranciscoSCOTT D  SANDELL10% Owner BALTIMORESAP Ventures Fund I, L.P.10% Owner PALO ALTOSapphire Ventures (GPE) I, L.L.C.PALO ALTOCHRISTOPHER J  SCHAEPEMENLO PARKGREGORY GEORGE  SCHOTTChairman and CEO ATHERTONCraig  ShermanPALO ALTOPeter W.  Sonsini10% Owner MENLO PARKCollins  StevenSan FranciscoRavi  Viswanathan10% Owner TIMONIUMJohn  VrionisMENLO PARKRob  WardPALO ALTOANN L  WINBLADDirector Persons related to DAVID M  MOTT - Tracon Pharmaceuticals, Inc.NamePositionCityM JAMES  BARRETT10% Owner BALTIMOREM JAMES  BARRETT10% Owner TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMLiang  BertrandSan DiegoPATRICIA L  BITARCFO SAN DIEGOAdams  BonneSan DiegoAdams  BonneSan DiegoBrookline Tracon Investment Fund II, LLC10% Owner BIRMINGHAMBROOKLINE TRACON INVESTMENT FUND LLCBIRMINGHAMLeigh  BryanSan DiegoLeigh  BryanSan DiegoTheuer  CharlesSan DiegoTheuer  CharlesSan DiegoTHEUER  CHARLESSAN DIEGOCSA Biotechnology Fund I, llcBIRMINGHAMCSA Biotechnology Fund II, LLCBIRMINGHAMRYAN D  DRANT10% Owner TIMONIUMAnthony A. Jr.  Florence10% Owner CHEVY CHASEAnthony A. Jr.  Florence10% Owner CHEVY CHASELOGAN  HSAN DIEGOKenji  HaradaSAN DIEGOHozoji  HironoriSan DiegoHironori  HozojiSAN DIEGOLobell  J.New YorkTwiford  J.San DiegoTWIFORD  J.SAN DIEGOTwiford  J.San DiegoSuper V3 Investment Limited Partnership  JAFCO10% Owner CHIYODA-KU, TOKYO 100-0004Super V3 Investment Limited Partnership  JAFCO10% Owner TOKYOCantrell  JamesSan DiegoBolton  JohnSan DiegoHarada  KenjiSan DiegoPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMWILLIAM R  LARUEDirector CARLSBADWILLIAM R  LARUESAN DIEGOH CASEY  LOGANChief Business Officer SAN DIEGOMATTINGLY  MARTINSAN DIEGOMARTIN A  MATTINGLYDirector CARLSBADMARTIN A  MATTINGLYSAN DIEGODAVID M  MOTT10% Owner GAITHERSBURGDAVID M  MOTT10% Owner TIMONIUMKwon  Myoung-OkSan DiegoNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMBITAR  PATRICIASAN DIEGOWALKER  PAULSAN DIEGOSCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMReal  SharonSan DiegoReal  SharonSan DiegoRONALD L  SHAZERChief Medical Officer SAN DIEGOPeter W.  Sonsini10% Owner MENLO PARKWORLAND  STEPHENSAN DIEGOCHARLES  THEUERPresident and CEO SAN DIEGOHofer  TimothyNew YorkJ Rainer  TwifordDirector NEW YORKJ Rainer  TwifordDirector SAN DIEGORavi  Viswanathan10% Owner TIMONIUMPaul Edward  WalkerDirector TIMONIUMHarry R  Weller10% Owner TIMONIUMComer  WilliamSan DiegoLARUE  WILLIAMSAN DIEGOSTEPHEN T  WORLANDDirector SAN DIEGOPersons related to DAVID M  MOTT - Cascadian Therapeutics, Inc.NamePositionCityACM Capital Partners, LLCSAN FRANCISCOAyer Capital Management, LP10% Owner SAN FRANCISCOAyer Capital Partners, LLCSAN FRANCISCOAyer Capital Partners, LLCSAN FRANCISCORobert  AzelbyDirector SEATTLEPETER J  BARRISBALTIMOREBIOTECHNOLOGY VALUE FUND II LPBIOTECHNOLOGY VALUE FUND II LPCHICAGOBIOTECHNOLOGY VALUE FUND II LPCHICAGOBIOTECHNOLOGY VALUE FUND II LPSAN FRANCISCOBIOTECHNOLOGY VALUE FUND L PBIOTECHNOLOGY VALUE FUND L PCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOBIOTECHNOLOGY VALUE FUND L PSAN FRANCISCOBiotechnology Value Trading Fund OS LPGRAND CAYMANS. Robert  BlairDirector BELLEVUEStephen  BurleySAN DIEGOBVF INC/ILBVF INC/ILCHICAGOBVF INC/ILSAN FRANCISCOBVF INC/ILCHICAGOBVF PARTNERS L P/ILBVF PARTNERS L P/IL10% Owner CHICAGOBVF PARTNERS L P/IL10% Owner SAN FRANCISCOBVF PARTNERS L P/ILCHICAGOBVF Partners OS Ltd.GRAND CAYMANGary  ChristiansonChief Operating Officer BELLEVUEGary  ChristiansonChief Operating Officer SEATTLEGary  ChristiansonChief Operating Officer SEATTLEHenney  ChristopherSeattleHenney  ChristopherSeattleSpiegelman  DanielSeattleSpiegelman  DanielSeattleHausman  DianaSeattleWilliams  DouglasSeattleJULIA MARIE  EASTLANDCFO & VP Corp. Dev. SEATTLEJULIA MARIE  EASTLANDCFO & VP, CORP. DEVELOPMENT SEATTLEJULIA MARIE  EASTLANDCFO & VP Corp. Dev. SEATTLEGwen A.  FyfeDirector SUNNYVALEChristianson  GarySeattleChristianson  GarySeattleGrowth Equity Opportunities IV, LLCTIMONIUMDIANA  HAUSMANChief Medical Officer SEATTLEDIANE  HAUSMANSEATTLECHRISTOPHER S  HENNEYDirector SEATTLECHRISTOPHER S  HENNEYDirector SEATTLECHRISTOPHER S  HENNEYDirector SAN DIEGOCHRISTOPHER S  HENNEYDirector SEATTLEINVESTMENT 10 LLCCHICAGORichard L.  JacksonDirector BELLEVUERichard L.  JacksonDirector CINCINNATIRichard L.  JacksonDirector SEATTLERichard L.  JacksonDirector SEATTLESTEVEN P  JAMESDirector Venkatesan  JaySeattleEastland  JuliaSeattleEASTLAND  JULIASEATTLEShashi  KaranSEATTLEShashi K.  KaranCorporate Controller SEATTLEROBERT L  KIRKMANPresident & CEO SEATTLEROBERT L  KIRKMANPresident/CEO BELLEVUEROBERT L  KIRKMANSEATTLEROBERT L  KIRKMANPresident & CEO SEATTLELynn  KirkpatrickChief Scientific Officer TUCSONMARK N  LAMPERTDirector SAN FRANCISCOMARK N  LAMPERTSAN FRANCISCOMARK N  LAMPERTSAN FRANCISCOMARK N  LAMPERTSAN FRANCISCOTED W  LOVEDirector SUNNYVALETED W  LOVEDirector SEATTLEJOSHUA  MAKOWERDAVID M  MOTTGAITHERSBURGScott Dunseth  MyersPresident and CEO HACKENSACKNEA 15 GP, LLCTIMONIUMNEA Partners 15, L.P.TIMONIUMNew Enterprise Associates 15, L.P.TIMONIUMSCOTT ROBERT  PETERSONChief Scientific Officer SEATTLESCOTT ROBERT  PETERSONChief Scientific Officer SEATTLEJackson  RichardSeattleJackson  RichardSeattleKirkman  RobertSeattleKirkman  RobertSeattleJon  SakodaTIMONIUMSCOTT D  SANDELLBALTIMOREPeterson  ScottSeattleKaran  ShashiSeattlePeter W.  SonsiniMENLO PARKDANIEL K  SPIEGELMANDirector PALO ALTODANIEL K  SPIEGELMANDirector SEATTLEDANIEL K  SPIEGELMANDirector SEATTLEDANIEL K  SPIEGELMANPALO ALTODANIEL K  SPIEGELMANDirector PALO ALTODANIEL K  SPIEGELMANDirector SEATTLEDANIEL K  SPIEGELMANDirector SEATTLEW VICKERY  STOUGHTONDirector BELLEVUEW VICKERY  STOUGHTONDirector WELLESLEY HILLSW. VICKERY  STOUGHTONDirector SEATTLEW. VICKERY  STOUGHTONDirector SEATTLEEdward A.  TaylorCFO, VP Fin Admin, Sec EDMONTONEdward A.  TaylorCFO, VP Fin & Admin, Sec EDMONTONLove  TedSeattleJay  VenkatesanSAN FRANCISCOJay  VenkatesanSAN FRANCISCOJay  VenkatesanSAN FRANCISCOJay  VenkatesanEVP and General Manager SEATTLEJay  VenkatesanEVP and General Manager SEATTLERavi  ViswanathanTIMONIUMStoughton  W.SeattleStoughton  W.SeattleLuke Nathaniel  WalkerSEATTLEMichael C.  WelshBELLEVUEDOUGLAS E  WILLIAMSDirector SEATTLEDOUGLAS E  WILLIAMSDirector SEATTLEPersons related to DAVID M  MOTT - ARDELYX, INC.NamePositionCityJenkins  AnnalisaFremontJenkins  AnnalisaFremontNarani  ArasaratnamVP, Corporate Controller FREMONTM JAMES  BARRETT10% Owner BALTIMOREM JAMES  BARRETT10% Owner TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMRobert B  BazemoreDirector LEXINGTONWilliam C  Bertrand JRDirector GAITHERSBURGJeremy S  CaldwellEVP, Chief Scientific Officer FREMONTDominique  CharmotFREMONTCMEA Ventures VII LP10% Owner SAN FRANCISCOCMEA Ventures VII LP10% Owner SAN FRANCISCOCMEA Ventures VII LP10% Owner SAN FRANCISCOCMEA VENTURES VII (PARALLEL) LPSAN FRANCISCOCMEA VENTURES VII (PARALLEL) LPSAN FRANCISCOCollier  DavidFremontMott  DavidFremontMott  DavidFremontRosenbaum  DavidFremontRosenbaum  DavidFremontCharmot  DominiqueFremontRYAN D  DRANT10% Owner BALTIMORERYAN D  DRANT10% Owner TIMONIUMGrammer  ElizabethFremontGrammer  ElizabethFremontAnthony A. Jr.  Florence10% Owner CHEVY CHASERingold  GordonFremontRingold  GordonFremontELIZABETH A  GRAMMERSVP, General Counsel FREMONTELIZABETH A  GRAMMERVP, General Counsel FREMONTJeffrey W  JacobsSVP, Technical Operations FREMONTJeffrey W  JacobsVP, Chemistry FREMONTFrechet  JeanFremontJacobs  JeffFremontAnnalisa  JenkinsDirector FREMONTCaldwell  JeremyFremontCaldwell  JeremyFremontGEORGE  JUEVP, Operations FREMONTGEORGE  JUEFREMONTGEORGE  JUEVP, Operations & Facilities FREMONTMark  KaufmannChief Financial Officer FREMONTMark  KaufmannChief Financial Officer FREMONTPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMPaul  KornerEVP, Chief Medical Officer FREMONTJOSHUA  MAKOWER10% Owner Kaufmann  MarkFremontKaufmann  MarkFremontRaab  MichaelFremontRaab  MichaelFremontDAVID M  MOTTDirector GAITHERSBURGDAVID M  MOTTTIMONIUMNEA 12 GP, LLCBALTIMORENEA 12 GP, LLCTIMONIUMNEA 15 GP, LLC10% Owner TIMONIUMPartners 12, Limited Partnership  NEABALTIMOREPartners 12, Limited Partnership  NEA10% Owner TIMONIUMEnterprise Associates 12, Limited Partnership  New10% Owner BALTIMOREEnterprise Associates 12, Limited Partnership  New10% Owner TIMONIUMKorner  PaulFremontSchultz  PeterFremontMICHAEL  RAABPresident & CEO BALTIMOREMICHAEL  RAABFREMONTMICHAEL  RAABPresident & CEO FREMONTRodgers  RichardFremontRodgers  RichardFremontGORDON  RINGOLDDirector REDWOOD CITYGORDON  RINGOLDFREMONTGORDON  RINGOLDDirector FREMONTBazemore  RobertFremontRichard J  RodgersDirector BLOOMINGTONRichard J  RodgersFREMONTRichard J  RodgersDirector FREMONTDavid P.  RosenbaumChief Development Officer FREMONTDavid P.  RosenbaumSVP, Drug Development FREMONTJon  Sakoda10% Owner TIMONIUMSCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMPETER G  SCHULTZDirector LAJOLLAPETER G  SCHULTZDirector FREMONTReginald  SeetoChief Operating Officer FREMONTBryan  ShawFREMONTPeter W.  Sonsini10% Owner MENLO PARKRavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREBertrand, Jr.  WilliamFremontPersons related to DAVID M  MOTT - APPIAN CORPNamePositionCityBiddle,  A.G.W. IIIBethesdaAbdiel Capital Advisors, LPNEW YORKAbdiel Capital LPNEW YORKAbdiel Capital Management, LLC10% Owner NEW YORKAbdiel Qualified Master Fund LPNEW YORKM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREAlbert G.W.  Biddle IIIDirector RESTONPrashanth  BoccassamDirector RESTONMatthew W  CalkinsCEO and President MCLEANMichael G  DevineDirector COLUMBIAAnthony A. Jr.  Florence10% Owner CHEVY CHASEWeller  HarryTimoniumEdward L  HughesCAMBRIDGEPATRICK J  KERINS10% Owner BALTIMOREBobbie G  KilbergDirector BLACKSBURGRobert Charles  KramerGeneral Manager RESTONMark Steven  LynchRESTONWilson  MarcRestonCalkins  MatthewRestonBeckley  MichaelRestonMulligan  MichaelRestonColin T.  MoranNEW YORKDAVID M  MOTT10% Owner GAITHERSBURGMichael J.  MulliganDirector RESTONNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMNovak Biddle Co V, LLC10% Owner BETHESDANovak Biddle Venture Partners V L PLANDOVERE Rogers  Novak JRWASHINGTONBoccasam  PrashanthRestonKramer  RobertRestonSCOTT D  SANDELL10% Owner BALTIMOREPeter W.  Sonsini10% Owner MENLO PARKRavi  Viswanathan10% Owner TIMONIUMChristopher  WintersRESTONPersons related to DAVID M  MOTT - Mersana Therapeutics, Inc.NamePositionCityPROTOPAPAS  ANNACAMBRIDGEM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREDonald A  BergstromCAMBRIDGEBlank  BurkhardCambridgeClarke  C.CambridgeBoyd  C.CambridgeMOTT  DAVIDCAMBRIDGEMott  DavidCambridgeBergstrom  DonaldCambridgeBERGSTROM  DONALDCAMBRIDGEJONES  ELAINECAMBRIDGEJack  EvaCambridgeJACK  EVACAMBRIDGEAnthony A. Jr.  Florence10% Owner CHEVY CHASEFMR CORP BOSTONWayne  FosterCAMBRIDGEAndrew A. F.  HackCAMBRIDGEKristen  HegeSOUTH SAN FRANCISCOEva M.  JackCAMBRIDGEElaine V  JonesNEW YORKTsang  JoyceCambridgeOlson  JulieCambridgeHong  KarenCambridgeMichael J.  KaufmanCAMBRIDGEPATRICK J  KERINS10% Owner BALTIMORETimothy B  LowingerCAMBRIDGEVogelbaum  MartinCambridgeKAUFMAN  MICHAELCAMBRIDGEMetzger  MichaelCambridgeDAVID M  MOTTDirector GAITHERSBURGSara M.  NayeemTIMONIUMNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMBacopoulos  NicholasCambridgeBacopoulous  NicholasCambridgeLeone  PeterCambridgePark  PeterCambridgePARK  PETERCAMBRIDGEAnna  ProtopapasPresident and CEO CAMBRIDGESCOTT D  SANDELL10% Owner BALTIMORENayeem  SaraCambridgeNAYEEM  SARACAMBRIDGEPeter W.  Sonsini10% Owner MENLO PARKBeck  ThomasCambridgeBECK  THOMASCAMBRIDGELowinger  TimothyCambridgeLOWINGER  TIMOTHYCAMBRIDGERavi  Viswanathan10% Owner TIMONIUMFoster  WayneCambridgeFOSTER  WAYNECAMBRIDGEPersons related to DAVID M  MOTT - Roka BioScience, Inc.NamePositionCityM JAMES  BARRETTDirector BALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMJoshua H.  BilenkerWARRENLars  BoesgaardVice President, CFO BEDFORDDAVID  BONDERMANDAVID  BONDERMANFORT WORTHDAVID  BONDERMANFORT WORTH,Fred E  CohenDirector SAN FRANCISCOFred E  CohenFORT WORTHJAMES G  COULTERFORTH WORTHJAMES G  COULTERFORT WORTHJAMES G  COULTERFORT WORTH,McGirr  DavidWarrenMichael P.  DoyleDirector WARRENRYAN D  DRANT10% Owner TIMONIUMCohen  FredWarrenSAMUEL D  ISALYSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKBarret, PhD  JimWarrenSilverstein  JonathanWarrenBilenker, MD  JoshWarrenPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMBoesgaard  LarsWarrenBeth Duseau  MaryCEO and President HATFIELDAmyJo  McCardellSenior Vice President WARRENDAVID W J  MCGIRRDirector GREENWICHDAVID W J  MCGIRRDirector WARRENWatts  MichaelWarrenDoyle  MichaelWarrenDAVID M  MOTT10% Owner GAITHERSBURGDAVID M  MOTT10% Owner TIMONIUMWalter M.  NarajowskiSenior VP & General Manager WARRENNEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEATIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMValeriani  NicholasWarrenORBIMED ADVISORS LLCDirector ORBIMED ADVISORS LLCNEW YORKORBIMED ADVISORS LLC10% Owner NEW YORKOrbiMed Capital GP III LLCNEW YORKOrbiMed Capital GP III LLCNEW YORKOrbiMed Capital GP III LLCNEW YORKThomas  PaulSan DiegoThomas  PaulWarrenThomas  PaulWarrenSCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMJONATHAN  SILVERSTEINDirector NEW YORKJONATHAN  SILVERSTEINWARRENJONATHAN  SILVERSTEINDirector WARRENSTEVEN  SOBIESKISVP & Chief Financial Officer STEVEN  SOBIESKISVP & Chief Financial Officer WARRENSobieski  StevenWarrenSobieski  StevenSan DiegoSobieski  StevenWarrenPAUL  THOMASPresident and CEO BRANCHBURGPAUL  THOMASPresident and CEO WARRENTPG Group Holdings (SBS) Advisors, Inc.10% Owner FORT WORTHTPG Group Holdings (SBS) Advisors, Inc.10% Owner FORT WORTH,TPG Group Holdings (SBS) Advisors, Inc.FORT WORTHNICHOLAS J  VALERIANIDirector NEW BRUNSWICKRavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREHarry R  Weller10% Owner TIMONIUMPersons related to DAVID M  MOTT - Ra Pharmaceuticals, Inc.NamePositionCityM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREPeter  BisgaardBOTHELLTreco  DouglasBostonTreco  DouglasCambridgeMathers  EdwardBostonMathers  EdwardCambridgeRamin  Farzaneh-FarChief Medical Officer CAMBRIDGERobert  HeftDirector CAMBRIDGEBroderick  JamesBostonLettman  JasonCambridgePATRICK J  KERINS10% Owner BALTIMOREBlack  KerryCambridgePeter  KolchinskyBOSTONKRISHNA KITTU  KOLLURI10% Owner BALTIMORESilverman  LaurenBostonJason  LettmannDirector PORTOLA VALLEYDavid Charles  LubnerExecutive V.P. & CFO WATERTOWNGoebel  MarkusCambridgeEdward T  MathersDirector GAITHERSBURGMorgenthaler Management Partners IX, LLCPORTOLA VALLEYMORGENTHALER VENTURE PARTNERS IX LP10% Owner MENLO PARKDAVID M  MOTT10% Owner GAITHERSBURGNEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEATIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMAG  NOVARTISCH-4002, BASELNovartis Bioventures Ltd10% Owner HAMILTONA/S  Novo10% Owner BAGSVAERDTIMOTHY R  PEARSONDirector ROCKVILLEBisgaard  PeterCambridgeRA Capital Biotech Fund LPBOSTONRA CAPITAL MANAGEMENT, LLCDirector BOSTONShah  RajeevCambridgeSimon  ReadCAMBRIDGESCOTT D  SANDELL10% Owner BALTIMORERajeev M.  ShahDirector BOSTONLaufik  TheodoreBostonDouglas A  TrecoCAMBRIDGERavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREPersons related to DAVID M  MOTT - TESARO, Inc.NamePositionCityLawrence M  AllevaDirector WALTHAMLawrence M  AllevaDirector WALTHAMJames O  ArmitageDirector OMAHAJames O  ArmitageDirector WALTHAMJames O  ArmitageWALTHAMOronsky  ArnoldWalthamOronsky  ArnoldWalthamM JAMES  BARRETT10% Owner BALTIMOREM JAMES  BARRETT10% Owner TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMSeidenberg  BethWalthamSeidenberg  BethWalthamGrant C.  BogleSr VP,Chief Commercial Officer WALTHAMHARVEY B  CASHMENLO PARKHARVEY B  CASHMENLO PARKBRUCE A  CLEVELANDMENLO PARKBRUCE A  CLEVELANDMENLO PARKEARL M  COLLIER JRDirector EARL M  COLLIER JRDirector WALTHAMMott  DavidWalthamMott  DavidLexingtonMott  DavidWalthamKeval  DesaiMENLO PARKKeval  DesaiMENLO PARKRYAN D  DRANT10% Owner BALTIMORERYAN D  DRANT10% Owner TIMONIUMCollier, Jr.  EarlWalthamChristopher B  EhrlichMENLO PARKChristopher B  EhrlichMENLO PARKEdward C  EnglishVP of Finance & Administration WALTHAMEdward C  EnglishVP of Finance & Admin & P.F.O. WALTHAMJoseph L  FarmerSr VP, GC and Secretary CAMBRIDGEDouglas  FisherMENLO PARKNicholson  GarryWalthamPHILIP T  GIANOSMENLO PARKPHILIP T  GIANOSMENLO PARKBogle  GrantWalthamJeffrey H.  HankeExecutive VP, R&D and CSO WALTHAMMary Lynne  HedleyPresident and COO LEXINGTONMary Lynne  HedleyWALTHAMMary Lynne  HedleyPres & Chief Scientific Off. WALTHAMW Stephen  HolmesMENLO PARKW Stephen  HolmesMENLO PARKMartin H. Jr.  HuberSVP & Chief Medical Officer WALTHAMInterWest Management Partners X, LLCMENLO PARKInterWest Management Partners X, LLC10% Owner MENLO PARKINTERWEST PARTNERS X LPMENLO PARKINTERWEST PARTNERS X LP10% Owner MENLO PARKArmitage  JamesWalthamHanke  JeffreyWalthamFarmer  JosephWalthamPatel  KavitaWalthamPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMJack A.  KhattarPresident, CEO ROCKVILLENina S  KjellsonMENLO PARKNina S  KjellsonMENLO PARKGilbert H  KlimanMENLO PARKGilbert H  KlimanMENLO PARKKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMC RICHARD  KRAMLICH10% Owner TIMONIUMAlleva  LawrenceWalthamMoulder, Jr.  LeonLexingtonMoulder Jr.  LeonWalthamMoulder, Jr.  LeonWalthamHuber  MartinWalthamHedley  MaryLexingtonLynne  Hedley  MaryWalthamLynne  Hedley  MaryWalthamDAVID M  MOTTDirector GAITHERSBURGDAVID M  MOTTDirector TIMONIUMLEON O  MOULDER JRChief Executive Officer BLOOMINGTONLEON O  MOULDER JRChief Executive Officer WALTHAMLEON O  MOULDER JRChief Executive Officer WALTHAMKHALED  NASRMENLO PARKKHALED  NASRMENLO PARKNEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEA10% Owner TIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMGarry A  NicholsonDirector WALTHAMOrlando  OliveiraSVP & GM, International WALTHAMARNOLD L  ORONSKYDirector MENLO PARKARNOLD L  ORONSKYMENLO PARKARNOLD L  ORONSKYDirector WALTHAMARNOLD L  ORONSKYDirector WALTHAMARNOLD L  ORONSKYDirector MENLO PARKARNOLD L  ORONSKYDirector MENLO PARKKavita  PatelDirector WALTHAMWalker  PaulLexingtonWalker  PaulWalthamTIMOTHY R  PEARSONExec. VP, CFO ROCKVILLETIMOTHY R  PEARSONEVP, CFO WALTHAMDouglas A  PepperMENLO PARKDouglas A  PepperMENLO PARKRodgers  RichardLexingtonRodgers  RichardWalthamRichard J  RodgersWALTHAMRichard J  RodgersExecutive VP & CFO WALTHAMThomas L  RoschMENLO PARKThomas L  RoschMENLO PARKSCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMBETH C  SEIDENBERGDirector BETH C  SEIDENBERGMENLO PARKBETH C  SEIDENBERGDirector WALTHAMBETH C  SEIDENBERGDirector WALTHAMPearson  TimothyWalthamRavi  Viswanathan10% Owner TIMONIUMPaul Edward  WalkerDirector TIMONIUMPaul Edward  WalkerDirector TIMONIUMHarry R  Weller10% Owner BALTIMOREHarry R  Weller10% Owner TIMONIUMPersons related to DAVID M  MOTT - Mirna Therapeutics, Inc.NamePositionCitySRINIVAS  AKKARAJULawrence M  AllevaDirector WALTHAMWard  AnaAustinMiguel  BarbosaChief Scientific Officer AUSTINM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMORECancer Prevention & Research Institute of TexasAUSTINDeYoung  CasiAustinEarl  ChristopherAustinSiegall  ClayAustinGoodman  CoreyAustinGoodman  CoreyAustinCasi  DeYoungChief Business Officer AUSTINMathers  EdAustinMathers  EdwardAustinJones  ElaineAustinJones  ElaineAustinMelrose  EvanAustinAnthony A. Jr.  Florence10% Owner CHEVY CHASEAlan  FuhrmanChief Financial Officer BOTHELLPeter  GreenleafDirector GAITHERSBURGJAMES  HEALYBRISBANEJon  IrvinVice President, Finance AUSTINIrvin  JonAustinElaine V  JonesDirector NEW YORKPATRICK J  KERINS10% Owner BALTIMORESinil  KimChief Medical Officer AUSTINKRISHNA KITTU  KOLLURI10% Owner BALTIMOREPaul  LammersPresident & CEO THE WOODLANDSAlleva  LarryAustinHohlfeld  LynneAustinEdward T  MathersDirector GAITHERSBURGWinkler  MatthewAustinWinkler  MatthewAustinAnand  MehraMENLO PARKPowell  MichaelAustinPowell  MichaelAustinDAVID M  MOTT10% Owner GAITHERSBURGNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMPerry  NisenDirector AUSTINVincent  O'NeillChief Medical Officer AUSTINLammers  PaulAustinLammers  PaulAustinPFIZER INC10% Owner MICHAEL  POWELLDirector SCOTT D  SANDELL10% Owner BALTIMORECLAY B  SIEGALLDirector BOTHELLKim  SinilAustinSofinnova Management VIII, L.L.C.MENLO PARKSofinnova Venture Partners VIII, L.P.10% Owner MENLO PARKPeter W.  Sonsini10% Owner MENLO PARKRavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREMatthew  WinklerDirector AUSTINPersons related to DAVID M  MOTT - Cerecor Inc.NamePositionCityThomas H  AasenDirector SAN DIEGOApple Tree Partners IV, L.P.PRINCETONARMISTICE CAPITAL, LLCDirector NEW YORKArmistice Capital Master Fund Ltd.GRAND CAYMANATP III GP, Ltd.PRINCETONM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREEUGENE A  BAUERDirector PALO ALTOSheldon  BehshadBaltimoreFraser  BernadineBaltimorePaterson  BlakeBaltimorePaterson  BlakeBaltimoreISAAC  BLECHDirector NEW YORKSteven  BoydNEW YORKSucoff  CaryBaltimoreSucoff, Jr.  CaryBaltimoreBauer  EugeneBaltimoreBAUER  EUGENEBALTIMOREBauer  EugeneBaltimoreBauer  EugeneBaltimoreLUKE  EVNINBOSTONO'Brien  FedericaBaltimoreO'Brien  FedericaBaltimoreAnthony A. Jr.  Florence10% Owner CHEVY CHASETodd  FoleyCAMBRIDGETorti  FrankBaltimoreANSBERT  GADICKEBOSTONPeter  GreenleafDirector GAITHERSBURGPhil  GutryDirector BALTIMOREUli  HacksellPresident and CEO SAN DIEGOSeth Loring  HarrisonSYDNEY, NSWBlech  IsaacBaltimoreBlech  IsaacBaltimoreBLECH  ISAACBALTIMOREBlech  IsaacBaltimoreVornov  JamesBaltimoreVornov  JamesBaltimoreCatsimatidis  JohnBaltimoreKaiser  JohnBaltimoreKaiser  JohnBaltimoreKaiser  JohnBaltimoreKAISER  JOHNBALTIMOREVAUGHN M  KAILIANJohn Joseph  KaiserChief Business Officer SAN DIEGOKrumeich  KarenBaltimorePATRICK J  KERINS10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner BALTIMOREPersson  MagnusBaltimorePersson  MagnusBaltimorePersson  MagnusBaltimorePERSSON  MAGNUSBALTIMORERonald  MarcusChief Medical Officer BALTIMOREMORRIS  MARIAMBALTIMOREMorris  MariamBaltimoreSukhatme  MayukhBaltimoreMariam E  MorrisChief Financial Officer BETHESDADAVID M  MOTT10% Owner GAITHERSBURGMPM ASSET MANAGEMENT INVESTORS BV5 LLCBOSTONMPM BIOVENTURES V GP LLCBOSTONMPM BIOVENTURES V, L.P.BOSTONMPM BIOVENTURES V LLCBOSTONNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMBlake M  PatersonBALTIMOREMagnus  PerssonDirector BALTIMOREGutry  PhilBaltimoreGUTRY  PHILBALTIMOREMazhari  RezaBaltimoreMazhari  RezaBaltimoreMarcus  RonaldBaltimoreMARCUS  RONALDBALTIMORESCOTT D  SANDELL10% Owner BALTIMOREJames Paul  ScopaS. SAN FRANCISCORowland  SharonBaltimoreRowland  SharonMarylandBehshad  SheldonDirector BALTIMOREBarer  SolBaltimoreBarer  SolBaltimorePeter W.  Sonsini10% Owner MENLO PARKAasen  ThomasBaltimoreAASEN  THOMASBALTIMOREHacksell  UliBaltimoreHACKSELL  ULIBALTIMORERavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREPersons related to DAVID M  MOTT - Epizyme, Inc.NamePositionCityAndrew R  AllenDirector BOULDERAndrew R  AllenDirector BOULDERAMGEN INCTHOUSAND OAKSAmgen Ventures LLC10% Owner THOUSAND OAKSAstellas Venture Fund I L.P.MENLO PARKAstellas Venture Management LLCMENLO PARKAstellas Venture Management LLCMENLO PARKM JAMES  BARRETT10% Owner BALTIMOREM JAMES  BARRETT10% Owner TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner BALTIMOREFOREST  BASKETT10% Owner TIMONIUMKENNETH  BATEDirector CAMBRIDGE,KENNETH  BATEDirector CAMBRIDGEBAY CITY CAPITAL FUND LLC10% Owner SAN FRANCISCOBay City Capital Fund V Co-Investment Fund, L.P.SAN FRANCISCOBay City Capital Fund V Co-Investment Fund LPSAN FRANCISCOBay City Capital Fund V, L.P.SAN FRANCISCOBAY CITY CAPITAL LLC10% Owner SAN FRANCISCOBay City Capital Management V LLCSAN FRANCISCORobert B  BazemorePresident & CEO LEXINGTONCELGENE CORP /DE/SUMMITCelgene European Investment Co LLC10% Owner SUMMITKevin T  ConroyDirector MADISONRobert A  CopelandPresident of Research and CSO CAMBRIDGEThomas O  DanielSUMMITRYAN D  DRANT10% Owner TIMONIUMLUKE  EVNIN10% Owner BOSTONTodd  FoleyBOSTONANSBERT  GADICKEBOSTONStephen  GarbaczPrincipal Accounting Officer CAMBRIDGECARL  GOLDFISCHERDirector SAN FRANCISCOCARL  GOLDFISCHERDirector BELVEDERERobert J  GouldDirector CAMBRIDGESusan E  GrafChief Business Officer BEDMINSTEREric  HedrickChief Medical Officer CAMBRIDGEPeter Tai-Ching  HoChief Development Officer CAMBRIDGEH Robert  HorvitzCAMBRIDGEVAUGHN M  KAILIANBOSTONPATRICK J  KERINS10% Owner BALTIMOREPATRICK J  KERINS10% Owner TIMONIUMKLEINER PERKINS CAUFIELD & BYERS XIII, LLC10% Owner MENLO PARKKRISHNA KITTU  KOLLURI10% Owner BALTIMOREKRISHNA KITTU  KOLLURI10% Owner TIMONIUMKPCB XIII Associates, LLC10% Owner MENLO PARKDAVID M  MOTTDirector GAITHERSBURGDAVID M  MOTTDirector TIMONIUMMPM Asset Management Investors BV4 LLCBOSTONMPM BioVentures IV GmbH & Co. Beteiligungs KGBOSTONMPM BioVentures IV GP LLCBOSTONMPM BioVentures IV LLCBOSTONMPM BioVentures IV QP LP10% Owner BOSTONMPM BioVentures IV Strategic Fund, L.P.BOSTONNEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEA10% Owner TIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMRICHARD F  POPSDirector CAMBRIDGERICHARD F  POPSDirector WALTHAMJason P  RhodesPresident, CFO and Treasurer CAMBRIDGEMatthew  RosChief Operating Officer CAMBRIDGESCOTT D  SANDELL10% Owner BALTIMORESCOTT D  SANDELL10% Owner TIMONIUMJames Paul  ScopaSOUTH SAN FRANCISCOBETH C  SEIDENBERGDirector BETH C  SEIDENBERGDirector MENLO PARKKazumi  ShiosakiDirector BOSTONAndrew E.  SingerEVP & CFO CAMBRIDGEVort John  VanderBOSTONRavi  Viswanathan10% Owner TIMONIUMHarry R  Weller10% Owner BALTIMOREHarry R  Weller10% Owner TIMONIUMYi  ZhangCAMBRIDGEPersons related to DAVID M  MOTT - Adaptimmune Therapeutics PLCNamePositionCityBehbahani  AliTimoniumLawrence M  AllevaDirector WALTHAMRafael  AmadoChief Medical Officer MALVERNM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREAli  BehbahaniDirector TIMONIUMWilliam C  Bertrand JRGAITHERSBURGGwendolyn Knowlton  Binder-SchollChief Technology Officer PHILADELPHIAMott  DavidTimoniumJonathan  Knowles  Dr.Abingdon, OxfordshireBarbara Gayle  DuncanDirector SOMERSETSigal  ElliottPrincetonAnthony A. Jr.  Florence10% Owner CHEVY CHASELaing  IanAbingdon, OxfordshireSAMUEL D  ISALYNoble  JamesAbingdon, OxfordshirePATRICK J  KERINS10% Owner BALTIMOREGiles Francis Bertram  KerrDirector OXFORDSHIREJonathan Kenneth Charles  KnowlesDirector BASELLANDKRISHNA KITTU  KOLLURIBALTIMOREIan Michael  LaingDirector OXFORDDAVID M  MOTTDirector GAITHERSBURGNEA 14 GP, LTDTIMONIUMNEA Partners 14, L.P.TIMONIUMNew Enterprise Associates 14, L.P.10% Owner TIMONIUMJames  NobleChief Executive Officer BRANFORDORBIMED ADVISORS LLCDirector OrbiMed Capital GP V LLCNEW YORKThompson  PeterNew YorkAdrian  RawcliffeChief Financial Officer BRENTFORD, MIDDLESEX, ENGLANDSCOTT D  SANDELL10% Owner BALTIMORECharles Elliott  SigalDirector PRINCETONPeter W.  Sonsini10% Owner MENLO PARKHelena Katrina  Tayton-MartinChief Operating Officer HUNGERFORDPeter A  ThompsonDirector BELLEVUERavi  Viswanathan10% Owner TIMONIUMHarry R  WellerBALTIMORETal Zvi  ZaksDirector NEWTON












 








CapRally




















Find Investors
Features
Pricing
About
Login
Sign Up









Results

Filter

All Sectors
Energy
Healthcare
Technology
Other


All Stages
Seed
Early
Growth


Argentina
Australia
Brazil
Canada
China
France
Germany
Hong Kong
India
Ireland
Israel
Japan
Jersey
Korea
Luxembourg
Russia
Singapore
Sweden
Switzerland
The Netherlands
United Kingdom
United States




Go








David Mott
General Partner // New Enterprise Associates

Menlo Park, CA
(650) 854-9499
dmott@nea.com





Companies Affiliations (9)



3-V Biosciences



Ardelyx



Epizyme 



MedImmune



Mersana Therapeutics



Omthera Pharmaceuticals



Prosensa



TESARO



Zyngenia




About David Mott
David M. Mott joined NEA in September 2008 as a General Partner focused on biopharmaceutical investments. Prior to joining NEA, he was President and Chief Executive Officer of MedImmune, subsidiary of AstraZeneca Plc, and Executive Vice President of AstraZeneca. Dave joined MedImmune in 1992 and served in roles of increasing responsibility including Chief Operating Officer, Chief Financial Officer, President and Chief Executive Officer as the company grew from a venture-backed startup (founded in 1988) into one of the top five biotechnology companies in the world. Ultimately, he initiated and executed the sale of MedImmune to AstraZeneca in June 2007 for $15.6 billion. In 2002, Dave founded MedImmune Ventures and chaired its investment committee through his departure from MedImmune. At the time of his departure in July 2008, MedImmune had annual revenues in excess of $1.5 billion, annual R&D in excess of $650 million and approximately 3,000 employees.\n\nPrior to joining MedImmune, Dave was a Vice President in the Health Care Investment Banking Group at Smith Barney, Harris Upham & Co. Inc. At Smith Barney, his activities included public and private equity and debt financings as well as merger and acquisition work for biotechnology, healthcare services, and medical product and device companies.\n\nDave is currently Chairman of 3-V Biosciences, TESARO, and Zyngenia and is a director of Ardelyx, Epizyme, Omthera, and Prosensa. He also serves on the Governing Board of St. Albans School.
Related Professionals (20)







Thomas R. Beck
Executive Partner







Nina Kjellson
General Partner







Beth Seidenberg
Investment Partner 







Risa Stack
Investment Partner 







George Daley
Venture Partner







Robert Millman
Managing Director







Kazumi Shiosaki
Managing Director







Robert Garland
Partner







Paul Walker
Partner







James Barrett
General Partner







Ali Behbahani
Principal







Sara Nayeem
Principal







Jay Moorin
Partner







Joyce Tsang
Partner







Isaac Ciechanover
Investment Partner







C. Boyd Clarke
Venture Advisor







Mark Leschly
Managing Partner  







Joshua Ruch
Managing Partner







Martin Vogelbaum
Partner  







Arnold Oronsky
General Partner

Show more...










Features
Pricing
About
Terms
Privacy
Help
Feedback
Contact Us


© 2017 CapRally, Inc. All rights reserved.













Mott Corporation
































 












Plans




Limited




Plus




Premium








            LimitedMonitor Your Competitors



Data

Access data on U.S. ocean freight imports from the last 3 months for all companies
You'll have access to data from the previous 6-months from the date of your search. We use a rolling date range, so you can always look back 6 months from the current date.




            LimitedMonitor Your Competitors



Data

Access data on U.S. ocean freight imports from the last 3 months for all companies
Access data on U.S. ocean freight imports from the last 3 months for all companies
You'll have access to data from the previous 3-months from the date of your search. We use a rolling date range, so you can always look back 3-months from the current date.




            PlusSmall & Medium Business



Data

Access data on U.S. ocean freight imports from the last 12 months for all companies
You'll have access to data from the previous 12-months from the date of your search. We use a rolling date range, so you can always look back 12-months from the current date.
U.S. ocean freight exports from January 1, 2014 to present for all companies




            Premium            Empire Builder



Data

Access data on U.S. ocean freight imports from November 2006 to the present for all companies
You'll have access to our entire database of shipping manifests of U.S. Ocean freight imports going back to November 2006.
U.S. ocean freight exports from January 1, 2014 to present for all companies





            LimitedMonitor Your Competitors



Usage

Track the shipping activities of your 3 chosen companies
Our Limited Plan lets you monitor the shipping activities of any three companies across all our databases. Be the first to know when your target company clears a shipment through customs in one of the countries we track.
3 Contact Info Requests Per Month
Our team of account managers and research assistants will help you find contact information for up to 3 companies in our database each month.
Download (CSV and XLS) 5k Records Per Month
If you're planning to do more in-depth research on the companies in our database, you should upgrade to the Plus or Premium plans, which allow more downloads.
Email Alerts for up to 3 Searches
If you need to track more than 3 companies, product segments, or trade lanes, you should upgrade to the Plus or Premium plan, which allow more email alerts.




            LimitedMonitor Your Competitors



Usage

10 Company Searches Per Day
10 searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry. If you're looking to connect with sales leads or do more in-depth research, you should upgrade to the Plus or Premium plan which allows more searches.
3 Contact Info Requests Per Month
Our team of account managers and research assistants will help you find contact information for up to 3 companies in our database each month.
Download (CSV and XLS) 1k Records Per Month
If you're planning to do more in-depth research on the companies in our database, you should upgrade to the Plus or Premium plan, which allow more downloads.
Email Alerts for up to 3 Company Searches
If you need to track more than 3 companies, product segments, or trade lanes, you should upgrade to the Plus or Premium plan, which allow more email alerts.




            Plus            Small & Medium Business



Usage

25 Searches Per Day
25 searches per day may be enough if you are just monitoring a few competitors or researching suppliers in a single industry. If you're looking to connect with sales leads or do more in-depth research, you should upgrade to the Premium plan which allows more searches.
25 Contact Info Requests Per Month
Our team of account managers and research assistants will help you find contact information for up to 25 companies in our database each month.
Download (CSV and XLS) 10k Records Per Month
If you're planning to do more in-depth research on the companies in our database, you should upgrade to the Premium plan, which allow more downloads.
Email Alerts for up to 5 Searches
If you need to track more than 5 companies, product segments, or trade lanes, you should upgrade to the Premium plan, which allow more email alerts.




            Premium            Empire Builder



Usage

50 Searches Per Day
 
50 Contact Info Requests Per Month
Our team of account managers and research assistants will help you find contact information for up to 50 companies in our database each month
Download (CSV and XLS) 25k Records Per Month
If you're planning to do more in-depth research on the companies in our database, contact the Sales Department to purchase more credits and export additional shipping records.
Email Alerts for up to 10 Searches





             Plus             Small & Medium Business



Features

Visual Mapping
Our Visual Mapping technology provides an instant snapshot of any company's trade connections. Navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart.







            Premium            Empire Builder



Features

Visual Mapping
Our Visual Mapping technology provides an instant snapshot of any company's trade connections. Navigate the global web of trading partners with the click of a mouse and visualize the relationships between companies many degrees apart.







            Limited            Monitor Your Competitors



Support

Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
Call or e-mail our Customer Service Agents. They will get back to as soon as possible to assist you with your data needs.




            Plus            Small & Medium Business



Support

Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
Call or e-mail our Customer Service Agents. They will get back to as soon as possible to assist you with your data needs.




            Premium            Empire Builder



Support

Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
Call or e-mail our Customer Service Agents. They will get back to as soon as possible to assist you with your data needs.
Dedicated Research Assistant
An experienced trade data specialist will serve as your dedicated account manager to locate hard-to-reach data, perform searches and compile reports on your behalf.




            Limited            Monitor Your Competitors



Data

Access data on U.S. ocean freight imports from the last 3 months for all companies
You'll have access to data from the previous 6-months from the date of your search. We use a rolling date range, so you can always look back 6 months from the current date.







X












                   Home                





                        How It Works                    



                            U.S. Data                        

                            Additional Countries                        

                            Our Datasets                        

                            Our Clients                        

                            IG Reviews                        

                            Videos                        

                            Pictures                        

                            Presentation                        



                   Plans & Pricing                

                    Search                

                  Contact Us                
Live Chat				

                    Free Demo                

                    Sign In                

                    Join Now                











English
中文
French










English



中文



French



 

Get global shipment alerts for Mott Corporation, $9.95 /month

Processing, please wait ...







Cardholder's Name


Tell us your Full Name



Credit Card No. 








Enter a valid Card No.



Exp. Date

1 January
2 February
3 March
4 April
5 May
6 June
7 July
8 August
9 September
10 October
11 November
12 December




2017
2018
2019
2020
2021
2022
2023
2024
2025
2026



Postal Code / Zip


(or Postal Code if not in the USA)




  Terms of Service




Submit















			                                                Service: 855-573-9976 
                        Sales: +1-855-573-9976

 Live Chat

Choose Language
 English
 中文
 French




 



Hi, may I help you with something?

An ImportGenius.com sales agent is available to answer your question.


							Chat Live Now						

						No, thanks.					







Sign Up






Home
How It Works
Plans & Pricing
Search
Contact Us


Live Chat

2
  



 



Mott Corporation

Mott,david exports to Mott Corporation through the port of Los Angeles, California        





 Call +1 (480) 744 2559




Import Genius






                                Our bill of lading data reveals the trading activities of Mott Corporation and millions of other manufacturers.                            


Learn More
Join Now




Request a Demo





Would you like to schedule a free demo?
We'd love to show you international trade data relevant to your own business.










Name




Email





Phone






Schedule A Free Demo


















Play muted


International Trade Starts With Our Data









Other companies in our database

 DISNEY THEME PARK MERCHANDISE (OLD
 STARBUCKS COFFEE SEATTLE
 FAMILY DOLLAR STORES,INC.
 PANASONIC CONSUMER ELECTRONICS COMP
 PING INC.
















View Sample Shipment Records
Shipment Alert Subscription
Contact This Company



Sign Up

 





Sample shipment record for Mott Corporation
Mott,david exports to Mott Corporation through the port of Los Angeles, California


                                Bill of Lading                            





Manufacturer / Shipper
Consignee



MOTT,DAVID
TONG-IN INTERNATIONAL MOVING CO., L ZIP CODE 140-872 TONG-IN 3RD BLDG, 81-2, HANGGANGRO-


MOTT,DAVID                COL
D_GBLOC MLNQ FLEET LOGISTIC CENTER PEARL HARBOR JPPSO-HAWAII CODE 800 4825 BOUGAINVILLE DRIVE



Notify Party
Marks and Numbers



MOTT,DAVID                COL
D_GBLOC MLNQ FLEET LOGISTIC CENTER PEARL HARBOR JPPSO-HAWAII CODE 800 4825 BOUGAINVILLE DRIVE



GBL-
QXAK0096088
MOTT,DAVID
GBL-
QXAK0096088
MOTT,DAVID





Master Bill of Lading Number
Container Number



APLU011228030


SEGU4987993
SEGU4987993


Product Description




--- CODE - #4 ---                            USED MILITARY HOUSEHOLD GOODS                MOTT, DAVID CVII                             DOD SPONSORED PERSONAL PROPERTY
--- CODE - #4 ---                            USED MILITARY HOUSEHOLD GOODS                MOTT, DAVID CVII                             DOD SPONSORED PERSONAL PROPERTY









Bill of LadingAPLU300745481Arrival Date2015-06-11Weight (LB)12,747Weight (KG)5,794UnitsCMQuantity9 LVNContainer Count1Voyage No.00190Port of LoadingPUSANPort of DischargeLOS ANGELES, CALIFORNIAVessel NameAPL PHILIPPINESCarrier CodeAPLUCountry Of OriginSouth KoreaPlace Of ReceiptBUSAN-PNIT, PUSAN 





Subscribe to access the complete shipping history for Mott Corporation. Join Now 







How will your business use our trade data?
If you're involved in international trade, our database of shipping manifests will help you find opportunities to grow your business.

Find Trading Partners You Can Trust
Monitor Competitors' Shipping Activities
Connect With Sales Prospects














                            "Very informative and great site and so quick. Pretty slick."
                        







Betty Fatzie

                                                                    President,                                 
                                                                    Lab Products, Inc.                                
                            






                            "The service was great, with a reasonable price and great results. We have now started using another supplier from China. We just ordered our first container from the new supplier and with the savings it more than paid for the ImportGenius.com service on the first container load."
                        







Cleve Kurz

                                
                                                                    Gifford Monument Works                                
                            






                            "Import Genius is not merely an investment for our organization, it’s a vital instrument to effectively manage our time. It has afforded us the ability to quickly segment, target and position ourselves in front of prospective clients. Thank you, Import Genius!"
                        







David Bryant

                                                                    Director of Business Development,                                 
                                                                    John S. James Co.                                
                            






                            "Import Genius data is fantastic for evaluating component manufacturers in China."
                        







Sanjay Dastoor

                                
                                                                    BoostedBoards.com                                
                            






                            "We have confidence that we're working with the best manufacturers in part because Import Genius showed us that they already supply some of the world's top brands"
                        







Yaniv Masjedi

                                                                    Vice President,                                 
                                                                    Nextiva.com                                
                            






                            "Import Genius is a highly informative tool for monitoring public companies' operating activities. It is an invaluable part of our research."
                        







Eric DeLamarter

                                                                    Managing Partner,                                 
                                                                    Half Moon Capital                                
                            






                            "We find new clients for our customs brokerage in the ImportGenius database almost every day"
                        







Jayson Gispan

                                                                    Customs Brokerage Operations Manager,                                 
                                                                    Flexport.com                                
                            






                            "ImportGenius is a great research tool. We use it to evaluate manufacturers to make sure we are working with only the highest quality, most reliable suppliers"
                        







Chris Friedland

                                                                    Founder / CEO,                                 
                                                                    Build.com                                
                            






                            "ImportGenius gave us visibility into the actual shipping histories of the manufacturers we were evaluating and helped us feel comfortable we were working with the best suppliers in China."
                        







Morena Simitic

                                                                    COO,                                 
                                                                    BellaBeat.com                                
                            
























Shipment Alert Subscription



                        Get e-mail alerts when Mott Corporation has new shipments.                        

Processing, please wait ...









Submit












Contact Mott Corporation







 



Name



Business



Email



Phone




Submit




Processing, please wait ...

 

 





Features



Save and Share Reports
Easily get your searches out of Import Genius and into your team’s hands for further analysis. Export your findings to XLS or CSV, or send reports via email. It’s the simple things that make our trade data even more valuable to you.



See the Supply Chain
Visual Mapping shows you exactly how your target companies and their trading partners connect. Search by shipper and see everyone they’ve shipped to. Or search by consignee and see all their suppliers. Zoom in on any company to see their own trading network. Dive deep into international trade and discover the links in anyone’s supply chain.



Get Real-time Shipment Alerts
Stay on top of your competitors, suppliers, and customers with real-time alerts. Just set up a search and get an email whenever a new shipment matches your terms. Import Genius lets you know the moment they bring in a rival product or start shipping to a new partner.








Mott Corporation
You've viewed 20 profile pages on Import Genius, which is the most we allow for free. Sign up for ImportGenius to get more details on over 3 million importers and exporters. It only takes seconds.






Sign Up for Import Genius! 








Plans




Limited
Monitor Your Competitors




Recommended Plan
Plus
Small & Medium Business




Premium
Empire Builder






Price





$
99
594
/month
for 6 months



                        Sign Up                    






$
199
1,194
/month
for 6 months



                        Sign Up                    






$
399
2,394
/month
for 6 months



                        Sign Up                    







Data




Access data on U.S. ocean freight imports from the last 3 months for all companies
View Details




Access data on U.S. ocean freight imports from the last 12 months for all companies
U.S. ocean freight exports from January 1, 2014 to present for all companies
View Details




Access data on U.S. ocean freight imports from November 2006 to the present for all companies
U.S. ocean freight exports from January 1, 2014 to present for all companies
View Details






Usage





Track the shipping activities of your 3 chosen companies
3 Contact Info Requests Per Month
Download (CSV and XLS) 5k Records Per Month
Email Alerts for up to 3 Searches

View Details





25 Searches Per Day
25 Contact Info Requests Per Month
Download (CSV and XLS) 10k Records Per Month
Email Alerts for up to 5 Searches

View Details





50 Searches Per Day
50 Contact Info Requests Per Month
Download (CSV and XLS) 25k Records Per Month
Email Alerts for up to 10 Searches

View Details






Features


 


Visual Mapping
View Details




Visual Mapping
View Details






Support




Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
View Details




Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
View Details





Our Customer Service Agents are available when you need them. Call in to receive helpful tips and training.
Dedicated Research Assistant

View Details






  






View All U.S. Imports
Instantly search 109,970,574 ocean freight records to monitor U.S. importers, research suppliers, generate sales leads and more.


As Featured In





















What is Import Genius





Who Uses Import Genius





Available Data Fields







What is Import Genius


												Import Genius reveals the trading activities of importers and exporters around the world.								

												We give you hard data about your overseas suppliers and domestic competitors. Using shipping databases from Customs agencies in the United States, Latin America, and India, Import Genius can help you find reliable new trading partners, monitor your competitors’ shipments, and keep an eye on your current suppliers and customers.								

												Our team of seasoned import-export veterans, cutting-edge software developers, and customer service professionals has worked for years to build the world's most powerful and accessible database of international trade intelligence.								



												We do this for a diverse client base that requires keen insight into international trade.								

												Our customers include some of the world's top importers, exporters, freight forwarders, logistics companies, manufacturers, investment banks, financial analysts, intellectual property attorneys, and more. They use our tools to:								

Research the trade activity of importers and suppliers
Identify and vet new sources for any kind of product
Monitor the competition and their trade connections
Generate sales leads for transportation and logistics companies
Track the activity of publicly-traded companies
Investigate and enforce intellectual property infringement
Ensure exclusive agent compliance




Who Uses Import Genius

Sourcing Professionals...

			Use our service to view shipping histories for suppliers.		

			We provide access to detailed customs records, letting you verify suppliers' true shipping volumes and U.S. customer lists. You can also look up your competing import firms to find where they buy their goods.		
+ Learn More
Competitive Intelligence Analysts...

			Use our service to learn where rivals source products.		

			We give clear insights into the importing volumes, new product releases, and broader competitive dynamics of your industry.		
+ Learn More


Sales & Marketing Teams...

			Use our service to generate sales prospects.		

			We give you the tools to target importers based on product type, location, shipping volumes, and more.		
+ Learn More
Financial Analysts...

			Use our service to monitor public companies' imports.		

			We offer rare data on the success or failure of new product launches, shipping trends and other operating data for companies in any industry.		
+ Learn More



Available Data Fields

Import Genius Data Fields

												By collecting the ocean freight bill of lading for all U.S. imports in our database, Import Genius provides unprecedented access to near real-time information on virtually every industry and company importing goods into the country.								

												For each shipment entering the U.S. by ocean, we provide access to the following information.								
Additional Fields Available for Some Shipments:

Phone Number
Fax Number
Email
Contact Person



List of Data Fields



ConsigneeThe company importing the shipment into the U.S.Consignee AddressThe address of the company importing the shipment into the U.S.ShipperThe overseas company exporting the shipment to the U.S.Shipper AddressThe address of the overseas company exporting the shipment to the U.S.Product DescriptionThe exporter's description of the shipment as it appears on the bill of lading or shipping manifestGross WeightThe gross weight of the shipment, excluding the weight of the actual container. This can appear in either pounds or kilograms at the discretion of the exporterNumber Of UnitsThe quantity of boxes customs would find if they were to open the shipment for inspection.VolumeThe volume of the shipment, generally defined in cubic meters or container base measurements (CBM)Arrival DateThe date the shipment arrives within the customs territory of the U.S.Foreign PortThe last port the shipment passes through before arriving in the U.S.Country Of OriginThe country of the last foreign port the shipment passes through before arriving in the U.S.U.S. PortThe U.S. port where the shipment enters the customs territory of the U.S.Carrier CodeThe four digit Standard Carrier Alpha Code of the ocean carrier or freight forwarder managing the transit of the shipmentVoyage NumberA unique code assigned to that particular sailing of the ship between two portsVessel NameThe name of the ship transporting the shipmentShip Registered InThe country where the ship is officially registeredBill Of Lading NumberThe unique number assigned to this particular shipment by the ocean carrier or freight forwarderContainer NumberThe unique number assigned to the ocean shipping container carrying the shipment in questionMarks & NumbersAny text or numbers appearing on the cartons 

















Import Genius

How It Works
Plans & Pricing
Our Trade Data Blog
Search
Latin Trade Data

Import Genius Reviews & Press Coverage
Who Uses Import Genius
Contact Us



Latest Posts




                                    Trump Properties Have…                                




                                    India, US palm oil imports…                                




                                    Chilean salmon exports…                                




                                    Limited Plan Now Available                                




                                    Solar panels: imports…                                




Company Profiles



                                    Weihai Jiashunxiang Garments                                



                                    Allstatepaperbos Company                                



                                    Sokol Pakging (hk)ltd                                



                                    Deadly Sins Brewing                                



                                    Snap-on Diagnostics C/o San Jise Di                                











                     
                                            109,970,574  Records in our database and counting





Customer Support Team: 

                    Tel:  855-573-9976
                    International: +1 480-745-3396
                    Fax: +1 602-428-9400
info@importgenius.com

                    8901 E Pima Center Pkwy, 
		    Suite 105 
                    Scottsdale, AZ 85258


Shanghai, China:

                    Tel: +86-21-63806036


                    Mobile No.: +86-13671737628
                    Fax Number: +86-21-63806036


Shenzhen, China
                    
                            Tel: +86-755-89517585
                            Mob: +86-13925258002
                            Fax: +86-755-89517585                



Have questions? We'll reply quickly!





									         		Type your info below								         		











Message



Submit

Processing, please wait ...

 

 

                Trainings, Demos, and General Contact All Available            
Or Call Us:
Service:

                    +1-855-573-9976                
Sales:

                    +1-855-573-9976                
Back to top

 





All Rights Reserved. Copyright © 2017. Trade Data Services, Inc. 0.3090
 






 

 




We're Offline
Please leave us a message



To chat with a representative of Import Genius, your browser needs to be Internet Explorer 9 or higher. Please fill out the form below and a representative will contact you as soon as possible.



Name



Email



Phone



Message



Send




X















 


David Mott
 | LinkedIn
 


























 









LinkedIn



















































Main content starts below.




David MottCoaching and Teaching Cross Country Skiing and Mountain Biking through Loppet FoundationLocationGreater Minneapolis-St. Paul AreaIndustryInformation Technology and ServicesPreviousHunt Imaging, Advanced Imaging Solutions (AIS), Xerox CorporationEducationUniversity of Minnesota - Carlson School of ManagementRecommendations2 people have recommended David466 connectionsView David’s full profile. It's free!Your colleagues, classmates, and 500 million other professionals are on LinkedIn.View David’s Full ProfileSummaryABOUT ME:-Used to chase leads . . . now I chase my grandsons.-Used to drive sales campaigns . . . now I drive to the cabin.-Used to pound the pavement . . .now I pound the mountain bike trails.-Used to log sales calls . . . now I log cross country skiing kilometers.-Used to tactfully work with executives . . .now I pick tacks on the sailboat course.-Used to go to Graph Expo . . . now I go to Laugh Expo  .  SUCCESSES:Hal Leonard Corp. -  Winning 5 yr. sales campaign resulted in 30% cost savings and doubling of print volumes.  Total sales revenue over $500K.Ameriprise Financial - Automated entire fleet of printers resulting in increased productivity, creating 50% reduction in labor, and reduction of 24 hours off service level agreement to customers.  Total sale over $750K.QuadGraphics - Accomplished first Xerox product class placement in WI. replacing incumbent vendor, and resulting in over $500K in revenue.  AG Edwards - $3+M order of capital equipment to streamline broker and customer statement printing, and reduce labor.PRODUCTS AND SERVICES SOLD:Hardware:  High-end production digital printers | ink jet printers | continuous feed printers | printer automation solutions | feeding and finishing solutions for production printers ( roll feed, cutters, folders, rewinders, stackers, collators, perfect binders, stitchers, bookletmakers) | print-to-mail solutions | multi-function printers and copiers | printer supplies | tonerSoftware:  document management | color printing management | workflow | job tracking | storage and archival |  composition.Services:  Printer and finishing equipment service | managed print services | facilities management | consulting and training services | specialty print solution services.Specialties: Lead generation | new customer acquisition | application analysis | networking and  new business development | value proposition and solution selling | complex sales and long sales cycles | ROI and TCO analysis | proposal generation | high level presentations | strategic and tactical contract negotiation | market positioning | strategic partnerships | effective e-mail campaigns | customer relationshipsYou can reach me at:  mottdw at hotmail dot comExperienceSenior Sales ExecutiveHunt ImagingJanuary 2013  –  June 2015 (2 years 6 months)Hunt Imaging continues its 90-year tradition of innovative product development with our proven line of high quality toners designed to maximize productivity, minimize maintenance, and reduce cost per page.  Hunt Imaging is an ISO 9001:2002 certified manufacturer with plants in the United States and Europe.  Our products are distributed worldwide by OEMs and as Hunt Imaging privately labeled products.  Buying directly from the manufacturer saves you money.  Our large inventories and distribution channels save you time.  All our toner supplies meet or exceed the OEM's product performance.  As Senior Sales Executive, I am responsible for after- market sales directly to users of high end production printers for all of North America.www.huntimaging.comSales/Senior Production SpecialistAdvanced Imaging Solutions (AIS)March 2011  –  June 2012 (1 year 4 months)Greater Minneapolis-St. Paul AreaSenior Production Specialist with Advanced Imaging Solutions, Minnetonka, MN.   I was brought in by owner/president to spearhead sales in growing production printing market, including AIS's entry into high end Kodak offerings.  Advanced Imaging Solutions is a Premier Document Technology Solution provider located in the Twin Cities since 1997.  AIS is locally owned and operated and one of the fastest growing companies in the industry.  AIS provides "Best In Class" product offerings from Konica Minolta, Kodak, Sharp, Lexmark, RISO, Kip and HP, as well as workflow software solutions from Planet Press, Prisim, EFI, and Creo.Sales Executive, Continuous Feed Printer DivisionXerox CorporationFebruary 2006  –  March 2011 (5 years 2 months)-Tasked with opening a six state region for Xerox largest revenue systems. -Successfully launched and brought to market Xerox’ high-speed continuous feed printing systems to the region which had zero install base. -Sold and installed first 495 and 650/1300 Continuous Feed Solutions into territory.   -Focal point for developing and coordinating strategic sales process from inception to negotiations and close. Sales involve complex solutions including integration of Xerox high speed continuous feed printers, 3rd party pre/post equipment, Xerox and 3rd party workflow and document management software solutions.  -Developed and implemented direct and second level sales support, technical expertise, application analysis, TCO modeling, proposal generation, and industry/competitive expertise to sales team of approximately 20 account reps.-Customers include Fortune 500 data centers, digital book printers, high volume direct mail concerns, and service bureaus specializing in high volume print production.Production Printer SalesDanka Office Imaging2004  –  2006 (2 years)Senior Sales RepresentativeData Sales Co.2002  –  2004 (2 years)Greater Minneapolis-St. Paul AreaRegional Sales ManagerLasermax Roll SystemsJanuary 1989  –  December 2002 (14 years)-Managed seven state territory, selling high dollar capital equipment for privately owned manufacturer in digital printing industry.-Employee #16, and first remote sales rep created with venture capital start up firm, developed territory from zero install base to industry leader.-Exceeded sales goal in 12 of 14 years with the company.  -Won and retained over 75 new customers during tenure. -Created over 300 system sales, with sales revenues over $30M total.  -Held company record for 20 consecutive months above sales goal.-Researched major accounts, developing consultative selling approach and strong value propostion strategies into Fortune 500 and National accounts.-Partnered with, and provided value added feeding and finishing solutions for IBM, Oce and Xerox high speed production printersSkillsEnterprise Solution SellingNew Business DevelopmentRevenue Growth GenerationCustomer Value PropositionC-Level SalesSolution SellingConsultative SellingStrategic Sales InitiativesLead GenerationPipeline GrowthLead TrackingCold CallingProduct PositioningEffective Writing SkillsAccount ManagementSee 35+Direct SalesSales ProcessHigh Level PresentationsProposal GenerationSituational Sales NegotiationContract NegotiationSales Cycle ManagementManaging Business PartnersStrategic PartnershipsApplication AnalysisROI AnalysisTarget MarketingEmail MarketingMajor AccountsNational AccountsLong Sales CyclesCapital Equipment SalesProduction PrintingPrint Production WorkflowPrint to MailDigital PrintingVariable Data PrintingInk Jet PrintingBindery SolutionsDirect MailProduction Print FinishingDriven By ResultsCustomer SatisfactionEnterprise Account ManagementSellingSalesBusiness DevelopmentPrint ManagementInkjetDocument ManagementSee lessHow's this translation?Great•Has errorsThanks for your help!OrganizationsLake Harriet Yacht Club - MinneapolisCommodore (President), Vice Commodore, Director, multiple committee chairsI have held a leadership role in this Twin Cities based organization for many years.“I've had the pleasure of working with Dave Mott on the Lake Harriet Yacht Club Board of Directors for several years. As Commodore, he exercised a balanced leadership style - taking input from the team, debating pros & cons, forming a direction and driving to a decision. Accomplishments included firing up a web site redesign, improving our racing & regatta schedule, revamping our scheduling process for safety boat duty, and establishing a new position to coordinate educational programs in the club. With his tenure in the sport, he was also well networked and able to bring insight from other clubs. Thanks to Dave, the Board was highly effective, identifying priorities and working them efficiently.”   Robert Netzer, Sr. Director, New Product Development, Seagate Technology “I worked with Dave Mott during his position as Commodore with the Lake Harriet Yacht Club. Dave did an excellent job communicating to club members the goals of the club, the tasks that we needed to accomplish and created discussions on the vision of the LHYC. He spearheaded efforts to retain our current members, attract new members and grow the club. Dave was effective in encouraging participation in the club for all members, from social events to racing clinics and regattas. It is evident that Dave's business skills played an important role in success of the Commodore position.”  Jayson Wold, Membership Committee Chair, Lake Harriet Yacht Club, worked directly with David EducationUniversity of Minnesota - Carlson School of ManagementBS, Business AdministrationBS, Business Administration1974  –  1977Graduated with honorsGustavus Adolphus CollegeLiberal ArtsLiberal Arts1972  –  1974Activities and Societies: Greek System, varsity cross country and trackRecommendationsA preview of what LinkedIn members have to say about David:Dave is an excellent sales professional with proven expertise supporting production printing solutions in a large geographical territory.  Dave does an excellent job working directly with clients understanding their business and operations in order to provide optimal solutions.  This level of involvement allows Dave to earn continued success through repeat business as his clients trust him as well as his recommendations for their operations.  Dave's sales knowledge and experience will benefit any organization.See moreSee lessI had the pleasure of working with and managing Dave Mott for multiple years at Roll Systems.  Dave was a consistent performer closing many new and substantial accounts. His track record for meeting and exceeding his numbers year after year was unparalleled. Dave possessed an excellent knowledge of the industry, key applications and numerous contacts in the production print space. 

He worked well with his fellow employees always willing to extend a helping hand or an encouraging word.  He was well respected by his customers for his follow through and business recommendations.  Dave displayed excellent communication skills in both written and oral presentations and grasped the key issues that would help demonstrate the most value to the customer in his business proposals.

On a personal note, he has an excellent sense of humor, is a committed father and family man and can be counted on to always perform at his highest level. He is a solid and professional sales individual and would be an excellent addition to any sales teamSee moreSee lessSign up to see who recommended DavidGroupsOutputLinksLinkedMinnesotaUniversity of Minnesota Alumni Association (UMAA)Toner Sales NetworkAftermarket Imaging Supplies Growth StrategiesNetworking with GracePrint Production ProfessionalsSee 4 moreSales / Marketing Executives (CSO/CMO/VP)Printing Industries of America Networking GroupThe Document Imaging GroupMidwest Sales ProfessionalsSee lessView David’s full profile to...See who you know in commonGet introducedContact David directlyView David’s Full ProfileNot the David you’re looking for? View moreView this profile in another languageEnglishChinese (Simplified)GermanPublic profile badgeInclude this LinkedIn profile on other websitesView profile badgesFind a different David MottFirst NameLast NameExample:  David MottDavid MottGeneral Partner at New Enterprise AssociatesUnited StatesDavid MottSr. iOS Engineer at Stealth Mode Startup CompanyUnited StatesDavid MottVice President & General CounselUnited StatesDavid MottTax Technology ProfessionalUnited StatesDavid MottExecutive Vice President, Willis Towers WatsonUnited StatesMore professionals named David MottLinkedIn member directory:abcdefghijklmnopqrstuvwxyzmoreBrowse members by country




















